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ABSTRACT 
In the eukaryotic cell, all proteins targeted to the extracellular medium, the plasma 
membrane, or specific organelles within the cell depend on transfer along the secretory 
pathway. Within this pathway newly synthesised proteins are folded, modified, and 
sorted, and an elaborate quality control machinery ensures that only proteins with 
correct conformations are transported to their final destinations. The functions of the 
secretory pathway are performed by a large number of proteins, such as chaperones, 
processing enzymes, and transport receptors. Although the roles of some of these 
proteins have been established, the functions of many remain to be elucidated. 
 
In this thesis, components of three different protein-protein complexes in the early 
secretory pathway have been studied by NMR spectroscopy and X-ray crystallography, 
with the aim of giving detailed structural information on each protein and gaining a 
deeper insight into the molecular mechanisms by which each protein performs its 
function and interactions. The work has resulted in the three-dimensional structures of 
MCFD2, a protein involved in transport of coagulation factors V and VIII, Erv41p, a 
vesicle protein proposed to play a role in glycoprotein processing and transport, and the 
co-chaperone P58IPK. 
 
NMR spectroscopy showed MCFD2 to be disordered in the absence of Ca2+ ions, but to 
adopt a predominantly ordered conformation upon binding of Ca2+. MCFD2 forms a 
Ca2+-dependent complex with the glycoprotein transport receptor ERGIC-53, and our 
data suggest that the requirement of Ca2+ for folding of MCFD2 is the mechanism 
behind the Ca2+-dependence of complex formation. In addition, we could explain the 
mechanism by which two missense mutations in MCFD2 cause the bleeding disorder 
combined deficiency of factor V and factor VIII. 
 
The first structure of Erv41p or any of its homologues was determined by X-ray 
crystallography. The protein was shown to form a β-sandwich with only limited 
structural homology to other proteins and this structure, in combination with the 
suggested role of Erv41p in glycoprotein processing, provided a starting point for our 
further studies to gain a better understanding of its function in the cell.  
 
X-ray crystallography was used to determine the structure of the co-chaperone P58IPK. 
P58IPK had been shown to interact with the chaperone BiP and stimulate its ATPase 
activity, and a conserved HPD motif in the J domain of P58IPK is known to mediate 
interactions between these types of proteins. The structure provided some initial 
insights into how the interaction with the chaperone BiP could be mediated. Further 
investigations of this interaction, using surface plasmon resonance biosensor 
technology, showed that additional interactions, beyond the J domain and the HPD 
motif, are important for the stimulating effect of P58IPK on BiP. 
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1 INTRODUCTION 
1.1 General introduction 
At any given time point, a typical eukaryotic cell carries out thousands of reactions. 
Many of these reactions are mutually incompatible; for example build-up and break-
down of the same metabolites occur simultaneously. Cells have evolved various 
approaches to avoid the chaos that would inevitably follow if these events took place 
side by side. One strategy, which is most developed in eukaryotic cells, is to separate 
the different metabolic processes into membrane-bound organelles. Although this 
solves one problem, it creates another, since the specific proteins constituting the 
machinery of each such organelle have to be selectively transported from where they 
are produced. In order to ensure that every protein arrives at the right compartment in 
its correct conformation, an elaborate system for processing and transport, known as the 
secretory pathway, has evolved.  
 
It has been estimated that one third of the more than 20000 translated proteins in 
eukaryotic genomes enter the secretory pathway. All of these proteins have to be 
folded, modified, and sorted for transport to their correct localisation, and the fidelity 
with which these tasks are performed by chaperones, processing enzymes, and transport 
receptors is nothing short of amazing. The importance of the secretory pathway is 
clearly established, and malfunction of different components of the processing and 
transport machinery has been linked to a number of diseases. A few examples include 
diabetes, different types of cancer, and bleeding disorders, such as the combined blood 
coagulation factor V and VIII deficiency. 
 
A proteomics study has identified more than 1400 proteins in the secretory pathway 
proteome, and although the roles of some of these are established, the functions of 
hundreds of the proteins remain unknown (Gilchrist et al., 2006). This highlights the 
challenge of providing a complete picture of each process in the pathway, which would 
require identification of the key components of every step and determination of how 
they interact to perform their functions. It is difficult to predict the roles of these 
uncharacterised proteins based on their sequences, and in order to fully elucidate the 
molecular mechanisms of the secretory pathway, determination of the three-
dimensional structure of each component in combination with studies of the many 
interactions between them will make valuable contributions. 
 
This thesis describes the work on three protein-protein complexes with different roles 
in the early secretory pathway. X-ray crystallography and nuclear magnetic resonance 
(NMR) spectroscopy have been applied to determine the structures of the coagulation 
factor binding protein MCFD2, the vesicle protein Erv41p, and the co-chaperone 
P58IPK. These studies have provided new insights into the proteins at a molecular level, 
and we also hope to have improved the general understanding of protein transport and 
processing in the early secretory pathway. 
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1.2 Overview of the early secretory pathway 
In the eukaryotic cell, the correct folding, processing and transport of proteins destined 
for organelles of the exocytotic pathway or secretion is dependent on events in the 
secretory pathway. The journey along this pathway starts at the endoplasmic reticulum 
(ER), and continues with stops at the ER-Golgi intermediate compartment (ERGIC) 
and the Golgi apparatus before the final destination is reached. Proteins travel between 
the different organelles in transport vesicles, which bud off from the membrane of one 
compartment, pass through the cytosol, and then fuse with the destination compartment 
to release their cargo. Anterograde transport in the direction from the ER towards the 
Golgi is mediated by vesicles created by the coat protein complex COPII, while COPI 
vesicles perform retrograde transport from the Golgi or the ERGIC back to the ER 
(Figure 1). 
 
Figure 1. Schematic overview of the secretory pathway. Cargo proteins destined for secretion leave the 
ER in COPII vesicles (black) that bud off from the membrane and travel to the ERGIC. In the ERGIC, 
cargo proteins are sorted for further transport towards the Golgi apparatus and beyond. Retrograde 
transport is mediated by COPI vesicles (grey) that transport escaped ER proteins, or proteins that cycle 
between the compartments of the secretory pathway, from the Golgi and the ERGIC back to the ER.  
 
 
Each organelle of the secretory pathway provides a unique environment that favours 
the gradual maturation of proteins. Chaperones assist folding and prevent unfolded 
proteins from aggregating, while other enzymes perform posttranslational 
modifications, such as glycosylation, alteration of the added glycan moieties, or 
formation of stabilising disulfide bonds. An elaborate quality control system is present 
at the early stages of the secretory pathway to ensure that only correctly folded proteins 
are transported to their final destinations. Proteins might undergo several rounds of 
unfolding and refolding before they are transported further, whereas terminally 
misfolded proteins are targeted for ER-associated degradation and retrotranslocated to 
the cytosol. 
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The endoplasmic reticulum 
Already in 1902, the Italian scientist Emilio Veratti applied light microscopy to observe 
what was later named the endoplasmic reticulum (Veratti, 1961). However, the findings 
were only published in Italian, which could explain the fact that the knowledge of this 
structure was almost forgotten for a long time (Mazzarello et al., 2003). In 1945 
however, Porter et al. noted the presence of a lace-like structure in tissue culture cells 
studied by electron microscopy. Based on its net-like appearance and location in the 
cytoplasm, the name endoplasmic reticulum, with the endoplasm being the innermost 
part of the cytoplasm and reticulum originating from the Latin word for small net, was 
chosen for the system (Porter & Thompson, 1948; Palade, 1956). Since then, the 
endoplasmic reticulum (ER) has been further studied and is now known to consist of a 
network of interconnected tubules and cisternae enclosed by a membrane. The ER 
membrane makes up more than half of the total membrane quantity in most cells, and 
the enclosed ER lumen can occupy more than 10% of the total cell volume (Alberts et 
al., 2002). The ER is the first station of the secretory pathway, and the lumen provides 
an environment that differs from the cytosol in several ways. For example, the ER has a 
distinct redox environment and dedicated chaperones that promote formation and 
isomerisation of disulfide bonds and oxidative protein folding (Csala et al., 2010). 
Furthermore, the total concentration of Ca2+ is approximately 1 mM in the ER (Prins & 
Michalak, 2011), which is significantly higher than the concentrations normally found 
in the cytosol (Pezzati et al., 1997). Many chaperones involved in folding and quality 
control are dependent on Ca2+ for their function, and depletion of Ca2+ is known to 
affect the maturation of a number of proteins (Ashby & Tepikin, 2001).  
 
The ER-Golgi intermediate compartment 
The ER-Golgi intermediate compartment (ERGIC), also known as vesiculo-tubular 
clusters or pre-Golgi intermediates, is a part of the secretory pathway only present in 
higher eukaryotes. Since its discovery, the identity of the ERGIC has been 
controversial; while some studies have proposed it to be a specialised domain of the ER 
(Sitia & Meldolesi, 1992), others have assigned it as a part or the Golgi (Mellman & 
Simons, 1992), but it is now considered to be a distinct compartment between the ER 
and the Golgi with unique properties (Appenzeller-Herzog & Hauri, 2006). Whereas 
the total Ca2+ levels in the ER and the Golgi are high, they are significantly lower in the 
ERGIC (Pezzati et al., 1997), and the pH is thought to be somewhere in between that of 
the ER (pH 7.2-7.4) and that of the Golgi (pH 6.0-6.7) (Paroutis et al., 2004; 
Appenzeller-Herzog & Hauri, 2006). These differences have been suggested to play a 
role in the function of the ERGIC as an important checkpoint for anterograde and 
retrograde transport, allowing secretory cargo to be concentrated and transported 
towards the Golgi, while ER resident proteins or proteins cycling between the 
compartments of the early secretory pathway are transported in the opposite direction. 
In addition to its function as a sorting station, the ERGIC has been suggested to 
function as a post-ER site for quality control and protein folding (Breuza et al., 2004; 
Appenzeller-Herzog & Hauri, 2006). 
 
The Golgi apparatus 
The Golgi apparatus was first observed in 1898 by Camillo Golgi as a basket-like 
network surrounding the nucleus in stained Purkinje cells (Farquhar & Palade, 1998). 
For a long time, the functions of the Golgi apparatus were unknown. It had been seen 
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that the Golgi was highly developed in secretory cells, but it was not until the 1960s 
that the role of this organelle in secretion and glycosylation of proteins was established. 
The Golgi consists of disc-shaped cisternae organised into stacks (Nakamura et al., 
2012). Proteins arriving from the ERGIC enter at the cis-Golgi network, travel through 
the series of cisternae, and leave the organelle at the trans-Golgi network, where they 
are sorted into carriers for further transport to their final destinations. Each cisterna 
within a stack constitutes a separate reaction compartment with unique biochemical 
composition and specific reactions carried out, and as they pass through the Golgi, the 
secretory proteins undergo a number of sequential modifications (Kornfeld & Kornfeld, 
1985; Nilsson et al., 1993). Among the events to which proteins are exposed in the 
Golgi, the most common are various types of glycoprotein processing reactions, such as 
trimming and remodelling of N-linked or attachment of O-linked oligosaccharides 
(Hanisch, 2001; Wilson et al., 2011). In contrast to the ER, there is no quality control 
mechanism in the Golgi to retain and reprocess or eliminate incorrectly processed 
proteins (Nakamura et al., 2012). Instead, the arrangement of the Golgi into separate 
cisternae prolongs the exposure of cargo to the processing enzymes, thereby increasing 
the fidelity of the pathway. 
 
 
1.2.1 Protein processing, folding and quality control in the ER 
The first step in the maturation of proteins in the secretory pathway occurs already 
during translocation into the ER. Secretory proteins are translocated cotranslationally, 
directed by an N-terminal signal sequence (Blobel & Dobberstein, 1975). This signal 
sequence is removed by endoproteolytic cleavage of the nascent polypeptide chain 
during translocation through the Sec61 pore (Paetzel et al., 2002). The multisubunit 
signal peptidase complex carrying out this function is thought to be located close to the 
Sec61 pore, with the active site near the lumenal surface of the ER membrane (Antonin 
et al., 2000).  
 
Also occurring concomitantly with protein translocation through the Sec61 pore is 
glycosylation of nascent proteins by attachment of asparagine-linked (N-linked) 
oligosaccharides. A 14-residue oligosaccharide core is transferred to proteins 
containing an Asn-X-Ser/Thr site by the oligosaccharyltransferase enzyme, which is 
composed of seven or eight transmembrane subunits and located close to the Sec61 
pore (Kelleher & Gilmore, 2006). It has been proposed that N-linked glycosylation of 
secretory proteins plays a role in folding and quality control. Firstly, addition of a 
hydrophilic glycan moiety influences the thermodynamic stability and solubility of a 
protein. Secondly, the glycans allow the glycoproteins to interact with various 
glucosidases, glycosyltransferases, and lectins such as calnexin and calreticulin, which 
play roles in sorting or folding of maturing proteins, or targeting of terminally 
misfolded proteins for degradation (Helenius & Aebi, 2004). These processing steps 
occur in a sequential and protein conformation dependent manner, thereby contributing 
to the quality control. 
 
Furthermore, mannose residues are added on serine or threonine side-chains of certain 
secretory proteins through O-linked glycosylation by protein O-mannosyltransferases. 
The specific role of O-linked glycosylation has not been established, but mutations in 
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genes encoding specific protein O-mannosyltransferases have been shown to affect 
degradation of misfolded proteins (Harty et al., 2001; Hirayama et al., 2008). 
  
Although the folding and maturation processes in the ER are similar to those in the 
cytosol, there are some modifications, necessary for the processing of secretory 
proteins, which are unique to the ER. For example, the redox conditions differ, and 
only in the oxidising environment of the ER is it possible for disulfide bonds, important 
for folding and stabilisation of proteins, to be formed. Enzymes such as those of the 
PDI (protein disulfide isomerase) and Ero1 (ER oxidoreductin 1) families assist and 
regulate these processes of oxidation of cysteines to form new disulfide bonds and 
isomerisation of non-native disulfides (Bulleid & Ellgaard, 2011). Members of the PDI 
family have been shown to interact with other components of the ER quality control 
machinery, e.g. chaperones (Kimura et al., 2005) or proteins involved in glycoprotein 
processing (Gauss et al., 2011). It has been suggested that differences in domain 
organisation between the PDIs determine which client proteins they interact with, and 
whether they interact with chaperones to promote further folding of their client proteins 
or deliver their clients to the ER-associated degradation pathway (Vitu et al., 2008; 
Barlowe & Miller, 2013). 
 
The existence of an ER quality control machinery was first suggested based on the 
discovery that misassembly of oligomeric viral proteins led to their inefficient export 
from the ER (Gething et al., 1986; Kreis & Lodish, 1986). Since then it has been 
established that secretory proteins have to pass a number of quality control checkpoints 
and might undergo multiple rounds of unfolding and refolding before they are ready to 
leave the ER. To assist in these processes, a number of chaperones recognise and bind 
to proteins with deviations from their native conformations, thereby retaining them in 
the ER, preventing them from aggregating and assisting in their folding (Ellgaard & 
Helenius, 2003). Some of the chaperones in the ER belong to classical chaperone 
families, such as the families of heat shock proteins (Hsp), Hsp40, Hsp70, and Hsp90, 
that are represented also in the cytosol, whereas others, for example the glycoprotein-
interacting chaperones calnexin and calreticulin, are unique to the secretory pathway.  
 
Only once a protein is correctly folded and assembled and has passed all quality control 
checkpoints it is allowed to leave the ER for further processing in the down-stream 
compartments of the secretory pathway. Proteins that, despite several rounds of 
unfolding and refolding, are judged to be terminally misfolded or incompletely 
processed are instead retrotranslocated from the ER to the cytosol for ubiquitination 
and proteasomal degradation in a process known as ER-associated degradation (ERAD) 
(Brodsky, 2012). 
 
 
1.2.2 Protein transport in the secretory pathway  
Secretory proteins that have been properly assembled and modified in the ER are then 
separated from proteins of the quality control machinery and sorted for further transport 
along the secretory pathway. This anterograde transport is mediated by vesicles that 
bud off from one membrane and travel through the cytoplasm to fuse with a 
downstream compartment. Other vesicles take care of retrograde transport in the 
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opposite direction, allowing retrieval of cycling or ER resident proteins, thereby 
maintaining the balance in the secretory pathway. 
 
Anterograde transport 
Vesicles leaving the ER for anterograde transport towards the ERGIC are created by 
the COPII (coat protein complex II) coat (Barlowe et al., 1994; Lee & Miller, 2007). 
This complex of proteins is responsible both for the formation of spherical vesicles 
from the ER membrane and for the recruitment of transport cargo to the vesicle. The 
budding of the COPII vesicles from the ER occurs at specific sites known as 
transitional ER or ER exit sites (Budnik & Stephens, 2009). Five proteins constitute the 
minimal COPII machinery: Sar1, Sec23, Sec24, Sec13, and Sec31 (Figure 2) (Barlowe 
et al., 1994). The initial step in vesicle formation is the recruitment of the small G 
protein Sar1 to the cytosolic side of the ER membrane, and the exchange of its 
nucleotide from GDP to GTP by the ER membrane-bound nucleotide exchange factor 
Sec12 (Barlowe & Schekman, 1993). GTP-binding activates Sar1 and leads to 
exposure and membrane insertion of an amphipatic α-helix that is thought to induce 
initial curvature of the membrane (Lee et al., 2005). Activated Sar1 recruits the 
heterodimeric complex of Sec23 and Sec24. Sec23 is a GTPase-activating protein 
(Yoshihisa et al., 1993), while Sec24 contains multiple independent domains that 
recognise specific sorting signals on transmembrane cargo proteins and transport 
receptors, and is responsible for the cargo-binding of COPII complexes (Miller et al., 
2002). After binding of cargo, the prebudding Sec23-24 complexes recruit 
heterotetrameric complexes of Sec13 and Sec31. These complexes assemble as an outer 
layer around the prebudding complexes and polymerise into a cage-like structure that 
further distorts and induces scission of the membrane, leading to formation of a vesicle 
that buds off from the ER (Stagg et al., 2006). The cargo-containing vesicle travels 
towards the ERGIC, where it is captured through cooperation between Rab GTPases 
and tethering factors. Fusion of the vesicle membrane and the ERGIC membrane is 
then assisted by interactions between a SNARE (soluble N-ethylmaleimide-sensitive 
factor attachment protein receptor) protein on the transport vesicle and its SNARE-
binding partner on the target membrane (Cai et al., 2007; Brocker et al., 2010). 
 
In cases when efficiency of export is not critical, for example concerning abundant, 
nonessential proteins, cargo molecules can be packed into vesicles by nonspecific bulk 
flow (Pfeffer & Rothman, 1987; Wieland et al., 1987; Thor et al., 2009; Barlowe & 
Miller, 2013). However, this mode of transport cannot account for the efficiency and 
selectivity with which certain proteins are exported from the ER. Instead, some cargo 
proteins contain specific signal sequences, allowing concentrative sorting into COPII 
vesicles (Malkus et al., 2002). Proteins transported by virtue of sorting signals can be 
divided into two classes: transmembrane cargo proteins that interact directly with the 
COPII coat and soluble cargo proteins that are linked to the coat through interaction 
with transmembrane cargo receptors (Barlowe, 2003). 
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Figure 2. COPII vesicle formation and selective uptake of cargo proteins. (A) Vesicle formation is 
initiated when Sar1 is activated by the nucleotide exchange factor Sec12. Activated GTP-bound Sar1 
recruits the Sec23-24 complex to the ER membrane. Transmembrane cargo proteins bind to Sec24 
directly via their cytosolically exposed sorting signals, while the interaction of soluble proteins with the 
Sec23-24 complex is mediated by transmembrane cargo receptors. (B) The prebudding complex recruits 
the outer layer Sec13-31 complex which polymerises, leading to distortion and scission of the membrane 
and formation of a COPII-coated vesicle loaded with cargo. (Adapted from Dancourt & Barlowe, 2010.) 
 
 
The first amino acid motif identified as a sorting signal of transmembrane cargo 
proteins was found in the cytoplasmic tail of the vesicular stomatitis virus glycoprotein 
(Nishimura & Balch, 1997). This diacidic Asp/Glu-X-Asp/Glu motif has been shown to 
interact directly with Sec23-24 of the COPII complex (Votsmeier and Gallwitz, 2001). 
Among other proteins depending on diacidic motifs for ER export are the angiotensin II 
receptor (Zhang et al., 2011), the cystic fibrosis transmembrane conductance regulator 
(Wang et al., 2004), and the potassium channels Kir1.1 and Kir2.1 (Ma et al., 2001). 
 
Another class of ER export signals comprises diaromatic or dihydrophobic motifs, such 
as Phe-Phe (FF), Tyr-Tyr (YY), Phe-Tyr (FY), or Leu-Leu (LL). Such a motif occurs 
for example in the human membrane lectin ERGIC-53, which contains two 
phenylalanines at the C-terminus required for exit from the ER (Kappeler et al., 1997). 
In its yeast homologues Emp46p and Emp47p the corresponding signal consists of two 
leucines (Sato & Nakano, 2002). Dihydrophobic motifs are also found in both partners 
of the complex between the ER vesicle (Erv) proteins Erv41p and Erv46p; an 
isoleucine-leucine motif in Erv41p and a phenylalanine-tyrosine motif in Erv46p are 
necessary for sorting of the complex into COPII vesicles (Otte & Barlowe, 2002). 
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Many of the proteins with dihydrophobic export signals form oligomeric complexes, 
and it has been suggested that the multiple signals present in such complexes are 
required for their efficient ER exit (Barlowe, 2003). This has been proposed to be a part 
of the quality control of the ER, only allowing properly assembled oligomers to 
continue along the secretory pathway. 
 
Recently, additional motifs for sorting into COPII vesicles have been discovered. 
Bovine anion exchanger 1 was shown to contain a new type of ER export motif for 
transmembrane proteins. This protein contains a Φ-X-Φ-X-Φ motif, where Φ is a 
hydrophobic amino acid and X is any amino acid, which has been shown to interact 
with Sec24 in the COPII coat (Otsu et al., 2013). A conserved triple arginine motif was 
also found to function as an ER export signal for the transmembrane α2B-adrenergic 
receptor, providing evidence of the association of G protein-coupled receptors with 
COPII vesicles (Dong et al., 2012). 
 
Soluble cargo proteins that are not transported by bulk flow depend on the association 
with transmembrane transport receptors for their packaging into COPII vesicles and 
export from the ER. It has been suggested that the transport receptors are important for 
the quality control and concentrative sorting in the ER, with only correctly folded and 
assembled cargo being recognised by their receptors and exported to downstream 
compartments of the secretory pathway (Barlowe, 2003). Although still not fully 
elucidated, a coordination between the ER folding machinery and sorting receptors has 
been indicated; a reduced binding of misfolded proteins to cargo receptors could help 
preventing competition between the two processes of folding and export (Dancourt & 
Barlowe, 2010). 
 
Based on their abundance in membranes of different organelles and transport 
intermediates of the early secretory pathway, several different proteins, including 
ERGIC-53 (Schweizer et al., 1988), were identified as potential cargo receptors. Their 
roles in sorting and transport were then confirmed by the observation that cells lacking 
a specific receptor displayed defective sorting and inefficient export of certain secretory 
proteins, whereas transport of other cargo proteins was unaffected (Dancourt & 
Barlowe, 2010). 
 
When a COPII vesicle arrives at its final destination, soluble cargo proteins need to be 
released from their receptors. Cargo release has, in some cases, been suggested to be 
controlled by changes in pH and/or Ca2+ concentration between different organelles, 
which would affect the interaction between cargo and receptor (Barlowe, 2003).  
 
Retrograde transport 
Retrograde transport is a vital process of the secretory pathway; ER resident proteins 
that have escaped the ER retention system need to be retrieved, and components of the 
trafficking machinery need to be recycled. Such retrograde vesicular transport from the 
Golgi and the ERGIC is mediated by COPI vesicles. The COPI coat consists of seven 
coatomer subunits that are assembled at the ERGIC or Golgi membranes in a single 
step, initiated by the small GTPase Arf1 (Serafini et al., 1991; Waters et al., 1991).  
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The retrograde transport of soluble ER proteins is generally mediated by the 
transmembrane KDEL receptor, which binds proteins bearing a KDEL sequence motif 
(Lewis & Pelham, 1990). It has been proposed that binding of cargo to the receptor 
induces conformational changes that are transduced to the cytosolic side of the 
membrane, where they contribute to uptake into COPI vesicles (Dancourt & Barlowe, 
2010). Proteins of the KDEL receptor family are highly conserved across species, 
although different versions of the C-terminal KDEL motif are recognised by different 
species (Lewis & Pelham, 1990; Lewis et al., 1990). Also within a species the 
specificities of different isoforms of the KDEL receptor are known to vary; as an 
example, the three homologous human KDEL receptors (ERD21, ERD22, and ERD23) 
have distinct but overlapping substrate preferences and have been shown to recognise 
over 50 variants of the KDEL motif (Raykhel et al., 2007). It has been shown that 
KDEL-receptor binding is strongly influenced by pH, and it has been proposed that the 
differences in pH between the compartments of the secretory pathway regulate the 
binding of cargo to the KDEL receptor in the Golgi and their release in the ER (Wilson 
et al., 1993). 
 
Another receptor mediating ER retrieval is the transmembrane protein Rer1p (Sato et 
al., 1997). Unlike other known cargo receptors, Rer1p recognises and binds to sorting 
motifs in the transmembrane domain of its cargo (Sato et al., 2001). Little is known 
about how the association of cargo with Rer1p is regulated to allow binding in the 
Golgi and the ERGIC and release in the ER. 
 
Several different motifs that mediate direct interaction between membrane proteins and 
the COPI coat have been identified. One of the best characterised motifs for retrograde 
sorting is the dilysine Lys-Lys-X-X (KKXX) motif, which can be found at the 
cytoplasmic C-terminal end of some membrane proteins and interacts directly with 
subunits of the COPI coat (Jackson et al., 1990). Another motif for ER retrieval is the 
arginine-based Arg-X-Arg motif, first identified in the ATP-sensitive K+-channel 
(Zerangue et al., 1999). Whereas the Lys-Lys-X-X motif has to be positioned close to 
the membrane surface for effective signal recognition, the Arg-X-Arg motif is 
functional only when spaced further from the membrane (Shikano & Li, 2003).  
 
 
1.3 The ERGIC-53/MCFD2 transport receptor complex 
ERGIC-53 
One of the most extensively studied transport receptors is ERGIC-53, also known as 
LMAN1. This protein, named based on its localisation in the ER-Golgi intermediate 
compartment and its molecular mass of 53 kDa, was initially identified using a 
monoclonal antibody generated against Golgi membranes (Schweizer et al., 1988). 
ERGIC-53 has since then been used as a marker for the ERGIC, where it is present at 
high concentrations, but it is also present in the ER and the cis-Golgi (Schweizer et al., 
1988; Hauri et al., 2000), and in both COPII and COPI vesicles (Tisdale et al., 1997; 
Wendeler et al., 2007).  
 
ERGIC-53 shares sequence and structural homology to leguminous lectins, a family of 
carbohydrate-binding proteins interacting specifically with mannose-rich 
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oligosaccharides in a Ca2+-dependent manner (Itin et al., 1996). This homology, in 
combination with sugar-binding studies, led to the suggestion of a role of ERGIC-53 in 
ER export of high-mannose glycoproteins. Since then, ERGIC-53 has been 
demonstrated to be involved in the transport of a number of glycoproteins, e.g. the 
lysosomal proteins cathepsin C (Vollenweider et al., 1998) and cathepsin Z 
(Appenzeller et al., 1999), and the glycosylated membrane protein nicastrin, a member 
of the γ-secretase complex (Morais et al., 2006). Additional support for a role of 
ERGIC-53 as a glycoprotein receptor came from the finding that mutations in the 
LMAN1 gene cause the bleeding disorder F5F8D (combined deficiency of factor V and 
factor VIII), which is characterised by impaired transport of the heavily glycosylated 
coagulation factors V and VIII (Nichols et al., 1998). For cathepsin Z, it has been 
shown that both N-linked glycans and a surface-exposed β-hairpin loop are important 
for the association with ERGIC-53 (Appenzeller-Herzog et al., 2005). A similar 
combination of a β-hairpin loop close to an N-linked oligosaccharide is also present in 
cathepsin C. In the interaction with coagulation factor VIII, a protein-protein interaction 
has also been shown to be a component of binding, in addition to the interaction with 
high-mannose glycans (Cunningham et al., 2003). 
 
ERGIC-53 contains a single transmembrane segment, a large N-terminal lumenal 
domain, and a short C-terminal cytosolic tail, which contains a diphenylalanine motif, 
governing interaction with COPII vesicles for anterograde transport (Kappeler et al., 
1997), and a dilysine motif, responsible for association with COPI vesicles for 
retrograde transport (Schindler et al., 1993). The lumenal domain is composed of two 
subdomains, a carbohydrate-recognition domain (CRD) and a membrane-proximal 
stalk domain. Crystal structures of the CRD have revealed a large binding site capable 
of accommodating high-mannose glycans (Velloso et al., 2002, 2003). The structures 
also support a Ca2+-dependent mechanism for binding of carbohydrates; the presence of 
two Ca2+ ions stabilises and coordinates two loop regions in the vicinity of the glycan-
binding site. The stalk domain is predicted to consist of four α-helices adopting a 
coiled-coil structure, and two cysteines in this domain form inter-molecular disulfide 
bonds that together with determinants in the transmembrane domain have been shown 
to mediate oligomerisation (Lahtinen et al., 1999; Nufer et al., 2003). ERGIC-53 has 
been demonstrated to exist as a homohexamer in the cell (Neve et al., 2005), and it has 
been shown that the oligomerisation state of ERGIC-53 is important for its transport 
receptor function (Nufer et al., 2003; Zheng et al., 2010).  
 
Although the mechanisms for some steps of ERGIC-53-mediated glycoprotein 
transport remain elusive, a model for its function as a transport receptor has been 
established (Figure 3). According to this model, hexameric ERGIC-53 binds folded 
glycoproteins in the ER and assists their transport with COPII vesicles to the ERGIC 
where dissociation of the cargo-receptor complex occurs as a consequence of the lower 
pH and Ca2+ concentration of this compartment. The glycoprotein is then further 
transported along the secretory pathway, while ERGIC-53 is recycled back to the ER in 
COPI vesicles (Hauri et al., 2000). 
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Figure 3. Schematic overview of the cargo receptor function and recycling of ERGIC-53. Hexameric 
ERGIC-53 binds to correctly folded glycoproteins in a Ca2+-dependent manner in the ER. The 
diphenylalanine motif in the cytosolic tail of ERGIC-53 mediates interaction with the Sec23-24 complex 
and recruits the cargo-receptor complex to COPII vesicles. The vesicles then travel to and fuse with the 
ERGIC, where the cargo proteins are released from ERGIC-53 triggered by the lower pH and Ca2+ 
concentration in this compartment. The released cargo proteins are transported to the Golgi for further 
modifications, while the dilysine motif of ERGIC-53 interacts with the COPI components and mediates 
the packaging of the transport receptor into vesicles for recycling back to the ER. (Adapted from Hauri et 
al., 2000.) 
 
 
MCFD2 
MCFD2 (multiple coagulation factor deficiency protein 2) was first linked to the 
secretory pathway when the gene encoding it was identified as the location of 
previously unexplained mutations causing F5F8D in patients with a wild-type LMAN1 
gene (Zhang et al., 2003). MCFD2 is known to interact with ERGIC-53, forming a 
stable Ca2+-dependent complex (Kawasaki et al., 2008). It has also been demonstrated 
to interact with coagulation factor VIII independently of ERGIC-53, while interaction 
between ERGIC-53 and factor VIII requires complex formation with MCFD2 (Zhang 
et al., 2005). Other cargo proteins are known to bind to ERGIC-53 in an MCFD2-
independent way, and the requirement of MCFD2 for transport of coagulation factors V 
and VIII would suggest a role for MCFD2 as a specific recruitment factor for this 
subset of glycoproteins (Nyfeler et al., 2006).   
 
MCFD2 is a soluble 16 kDa protein with an N-terminal ER localisation sequence and 
two C-terminal Ca2+-binding EF-hand motifs. MCFD2 has been shown to be localised 
  12
to the ER and the ERGIC, but in contrast to many other soluble ER proteins it lacks the 
KDEL sequence mediating ER retrieval, suggesting that localisation of MCFD2 is 
reliant on its interaction with ERGIC-53 (Zhang et al., 2003).  
 
Combined deficiency of factor V and factor VIII 
Combined deficiency of factor V and factor VIII (F5F8D) is a rare bleeding disorder 
first described by Oeri et al. in 1954. The disease is characterised by reduced plasma 
concentrations of the blood coagulation factors V and VIII, and is manifested as a mild 
to moderate bleeding tendency with common symptoms such as nose bleeds, gum 
bleeding and easy bruising. The disease is known to be inherited and caused by 
mutations in either of two proteins: ERGIC-53 (Nichols et al., 1998) or MCFD2 
(Nichols et al., 1998; Zhang et al., 2003). To date, at least 36 different mutations in the 
LMAN1 gene and 18 in the MCFD2 gene have been reported (Zheng & Zhang, 2013). 
All of the mutations in LMAN1 are null mutations except for two; one mutation causes 
a conformational change in the CRD and one breaks a disulfide bond important for 
oligomerisation (Yamada et al., 2009; Zheng et al., 2010). Some of the mutations in 
MCFD2 are also null mutations, but in this gene missense mutations are more common 
than in LMAN1; eight of the reported mutations result in single amino acid substitutions 
(Zhang et al., 2003; Zhang et al., 2006; Jayandharan et al., 2007; Ivaskevicius et al., 
2008; Zhang et al., 2008; Abdallah et al., 2010; Elmahmoudi et al., 2011). Except for 
one mutation found in the binding surface to ERGIC-53, all of these mutations give rise 
to a disordered or destabilised protein, which is unable to form a complex with ERGIC-
53, leading to an impaired transport of coagulation factors (Elmahmoudi et al., 2011). 
 
 
1.4 The Erv41-Erv46 complex 
In an attempt to identify proteins involved in transport along the secretory pathway in 
yeast, Otte et al. (2001) performed a reconstituted COPII vesicle budding assay in 
combination with proteomics studies. They identified the previously uncharacterised 
ER vesicle proteins Erv41p and Erv46p, named based on their localisation and 
molecular mass. Erv41p and Erv46p are both integral membrane proteins sharing the 
same overall topology, with one single large lumenal domain, two membrane-spanning 
helices close to the termini of the protein, and short N- and C-terminal tails on the 
cytosolic side of the membrane. The expression levels of Erv41p and Erv46p have been 
shown to be co-dependent, and immunoprecipitation experiments have demonstrated 
that the two proteins form a stable complex, most likely composed of one subunit of 
each.  
 
The C-terminal tails of both Erv41p and Erv46p contain a hydrophobic sequence that 
controls sorting into COPII vesicles for anterograde transport from the ER (Otte & 
Barlowe, 2002). The hydrophobic isoleucine-leucine sequence in the Erv41p tail is 
sufficient for binding of the complex to the COPII coat, but its combination with the 
phenylalanine-tyrosine sequence of Erv46p is required for export in COPII vesicles. 
Sucrose gradient fractionation has shown that the major fraction of the complex is 
located to the Golgi, with approximately 70% of all Erv46p, and a minor fraction is 
present in the ER. Removal of any of the COPII localisation signals leads to 
accumulation of the complex in the ER. Only Erv46p contains a signal for retrograde 
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transport; a conserved KKXX motif in its C-terminal tail binds to COPI vesicles (Otte 
& Barlowe, 2002; Orci et al., 2003), indicating that retrieval of Erv41p to the ER is 
dependent on binding to Erv46p. 
 
Erv41p and Erv46p are both conserved across eukaryotic species, and the human 
homologues, known as ERGIC2 or hErv41, and ERGIC3 or hErv46, share 30% and 
41% sequence identity, respectively, with their yeast counterparts. Erv41p and Erv46p 
have been demonstrated to be parts of a large heterogeneous complex with a molecular 
mass between 200 and 400 kDa (Breuza et al., 2004; Welsh et al., 2006). In humans, 
ERGIC1, also known as ERGIC-32, has been shown to be a part of the ERGIC2-
ERGIC3 complex through its interaction with ERGIC3 (Breuza et al., 2004). ERGIC1 
belongs to the same protein family as Erv41p and Erv46p, and shares their topology 
with a larger lumenal domain between two transmembrane segments. In contrast to 
Erv41p and Erv46p, ERGIC1 is mainly localised to the ERGIC. ERGIC1 is not 
believed to associate permanently with ERGIC2 and ERGIC3, but it has been 
suggested to stabilise monomeric ERGIC3 in the ER, thereby promoting correct 
assembly of the ERGIC2-ERGIC3 complex. It has also been demonstrated that the ER-
localised glucosidase II, Rot2p, which trims the two inner glucose residues from N-
linked oligosaccharides after glucosidase I has removed the most distal glucose, 
interacts with the Erv41p-Erv46p complex in yeast (Welsh et al., 2006). 
 
The exact function of the Erv41p-Erv46p complex in the early secretory pathway is not 
known. It has been proposed to play a role in sorting of cargo into transport vesicles, to 
help localising other components of the early secretory pathway, or to be involved in 
transport of lipids, but evidence now points towards a role in glycoprotein processing or 
transport (Otte et al., 2001). An in vitro assay showed that absence of either or both of 
the two proteins led to a decreased glycoprotein transport between ER and Golgi, 
suggested to be caused by a defect at the stage of vesicle fusion (Otte et al., 2001), and 
yeast strains lacking a cycling Erv41p-Erv46p complex display a mild glycoprotein 
processing defect (Welsh et al., 2006). 
 
Recently, both ERGIC1 and ERGIC3 have been linked to different types of cancer in 
human. The ERGIC1 gene has been shown to be highly expressed in prostate cancer 
tissue, and silencing of ERGIC1 induced antiproliferative effects in an ERG (v-ets 
erythroblastosis virus E26 oncogene homolog, avian) positive prostate cancer cell line 
(Vainio et al., 2012). Results also indicated that silencing of ERGIC1 could 
downregulate ERG mRNA expression, and it was suggested to be a potential drug 
target for ERG oncogene expressing tumours. 
 
The ERGIC3 gene has been demonstrated to be upregulated by the microRNA miR-
490-3p in hepatocellular carcinoma tissues and cell lines (Zhang et al., 2013). It was 
shown that ERGIC3 enhanced cell viability and colony formation, as well as stimulated 
cell migration and invasion ability. Data also indicated that ERGIC3 stimulated 
epithelial to mesenchymal transition, a process important for metastasis.  
 
ERGIC3 was also found to be upregulated in lung cancer tissues and in lung cancer cell 
lines, and the ERGIC3 protein was overexpressed in both tumours and cell lines (Wu et 
al., 2013). ERGIC3 was shown to have an effect on both cell proliferation and cellular 
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migration; reduced expression of ERGIC3 in a lung cancer cell line reduced the rate of 
proliferation and inhibited cellular migration, and overexpression of ERGIC3 in a 
normal cell line increased the rate of proliferation and promoted cellular migration. 
Based on the importance of the yeast homologue of ERGIC3, Erv46p, and its complex 
partner Erv41p in glycoprotein processing and transport (Welsh et al., 2006), it was 
speculated that the mechanism by which decreased expression of ERGIC3 affects 
cancer cell proliferation and migration could involve disruption of glucosidase activity 
and intracellular protein transport.  
 
 
1.5 The unfolded protein response 
The quality control machinery of the ER has evolved to ensure that no misfolded 
proteins are forwarded from the organelle; proteins that are not correctly processed or 
assembled are either refolded or designated for degradation. However, in some 
physiological and pathological conditions the capacity of the quality control is 
exceeded, leading to accumulation of misfolded proteins, a state termed ER stress. In 
order to cope with the ER stress and restore the normal functions of the ER, pathways 
collectively known as the unfolded protein response (UPR) are activated.  
 
Activation of the UPR is now known to have effects both on transcriptional and 
translational levels, and leads ultimately to reduced protein synthesis, increased 
capacity to fold nascent polypeptides in the ER, and increased retrotranslocation and 
degradation of misfolded proteins (Zhang & Kaufman, 2006). It is not only genes 
involved in protein folding, processing and degradation that are upregulated by the 
UPR, but also genes encoding proteins important for vesicle trafficking between the ER 
and the Golgi, or proteins with roles in lipid and inositol metabolism. This proves the 
importance of the unfolded protein response for integration of the functions of the 
secretory pathway and maintenance of ER homeostasis (Barlowe & Miller, 2013). In 
cases when ER homeostasis cannot be re-established, prolonged UPR signalling leads 
to apoptosis, thereby protecting the organism from accumulation of cells that are unable 
to ascertain the fidelity of protein production (Walter & Ron, 2011).  
 
There are three major regulators of the metazoan UPR (Figure 4): IRE1 (inositol-
requiring enzyme 1), ATF6 (activating transcription factor 6), and PERK (RNA-
activated protein kinase-like ER kinase). These are all transmembrane proteins which 
sense abnormal conditions in the ER lumen and transmit signals across the membrane 
to the cytosol, from where they are further passed on to the nucleus (Gardner et al., 
2013).  
 
IRE1 is the regulator of the most conserved branch of the UPR, and is the only ER 
stress sensor present in all eukaryotes (Mori, 2009). Apart from its N-terminal lumenal 
sensor domain, IRE1 contains cytosolic kinase and RNase domains at its C-terminus 
(Gardner et al., 2013). Upon accumulation of misfolded proteins in the ER, IRE1 
oligomerises and is phosphorylated in trans by other IRE1 molecules, leading to 
activation of the kinase and RNase domains (Shamu & Walter, 1996). The activated 
RNase domain specifically cleaves its mRNA substrate, yielding a spliced mRNA that 
is translated to the active form of the UPR-specific transcription factors XBP1 in 
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metazoans (Yoshida et al., 2001), or HAC1 in yeast (Cox & Walter, 1996). These 
transcription factors, in turn, directly mediate upregulation of UPR target genes, such as 
ER chaperone genes and genes encoding components of the ERAD machinery (Travers 
et al., 2000; Yoshida et al., 2001). In metazoans, IRE1 also mediates degradation of a 
subset of mRNAs encoding membrane and secreted proteins, thereby decreasing the 
uptake of proteins to the ER (Hollien & Weissman, 2006). 
 
 
 
Figure 4. Schematic overview of the unfolded protein response. In unstressed cells BiP binds to the 
lumenal domains of the three stress sensors IRE1, PERK, and ATF6 and keep them in an inactive state. 
In the event of ER stress, BiP is sequestered from the stress sensors to bind to un- or misfolded proteins, 
and the released sensors are activated. Activation of IRE1 leads to splicing of the mRNA encoding the 
transcription factor XBP1, and the translated transcription factor induces expression of different UPR 
target genes. IRE1 also mediate degradation of specific mRNAs, leading to a decreased amount of 
proteins translocated into the ER. Activated PERK phosphorylates eIF2α, inhibiting global mRNA 
translation to reduce the protein load in the ER, and increasing the specific translation of mRNA 
encoding the transcription factor ATF4, which activates UPR target genes. Upon activation, ATF6 travels 
to the Golgi where it is cleaved, and its cytosolic transcription factor domain is released and free to enter 
the nucleus to activate transcription of UPR target genes. (Adapted from Cao & Kaufman, 2012.) 
 
 
In response to ER stress, autophosphorylation and activation of the cytoplasmic kinase 
domain of PERK enable phosphorylation of eukaryotic translation initiation factor 2 α 
(eIF2α) (Harding et al., 1999). This inhibits general mRNA translation, resulting in a 
decreased protein load in the ER, but also increases the translation of some specific 
mRNAs, such as that encoding the transcription factor ATF4, which activates 
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downstream UPR target genes (Harding et al., 2000). One of these encodes the 
transcription factor CHOP, which controls genes involved in apoptosis (Wang et al., 
1998; Zinszner et al., 1998). 
 
The third UPR regulator, ATF6, is synthesised as a transmembrane protein with a 
lumenal ER stress-sensing domain and a cytosolic bZIP (basic leucine zipper) 
transcription factor domain. Upon exposure to high levels of misfolded proteins, it 
travels from the ER to the Golgi apparatus where it is proteolytically cleaved, and the 
transcription factor domain is released and enters the nucleus (Haze et al., 1999). There, 
it binds to the ER stress response element and activates transcription of UPR target 
genes similar to those transcribed in response to IRE1 signalling (Yoshida et al., 1998; 
Haze et al., 1999; Adachi et al., 2008). 
 
An additional central player in the UPR is the molecular chaperone BiP. BiP has been 
shown to form stable complexes with the lumenal stress-sensing domains of IRE1, 
PERK and ATF6 in unstressed cells, keeping them in an inactive state, and to 
dissociate from the UPR regulators in the event of ER stress (Bertolotti et al., 2000; 
Okamura et al., 2000;  Ma et al., 2002; Shen et al., 2002a). BiP is also known to bind 
directly to newly synthesised proteins in a transient manner, and more permanently to 
misfolded or unassembled proteins (Gething, 1999). According to the most supported 
view of how ER stress initiates the UPR, high concentrations of unfolded proteins 
compete with the ER stress sensors for BiP-binding (Kimata et al., 2003; Carrara et al., 
2013). When BiP is sequestered from the lumenal sensor domains, they are activated 
and the stress signal can be propagated via their cytosolic domains. Moreover, BiP 
itself is one of the proteins that are upregulated upon accumulation of misfolded 
proteins and UPR activation (Kozutsumi et al., 1988). It has been suggested that BiP 
expression is feed-back regulated on a translational level, helping the cell to fine-tune 
BiP levels in order to prevent ill-timed UPR (Gulow et al., 2002). 
 
 
1.6 The Hsp70-Hsp40 chaperone system 
The heat shock response and the heat shock proteins were first discovered by Ritossa in 
the 1960s, when he discovered that elevated temperatures gave rise to a different 
pattern of RNA synthesis in Drosophila melanogaster (Ritossa, 1962, 1996). Since 
then, it has been shown that a number of environmental and pathological events, 
including those that activate the unfolded protein response, increase the expression of 
heat shock proteins. Although first discovered in connection with the response to 
cellular stress, members of the heat shock families are also expressed in non-stressed 
conditions, acting as chaperones that are important for the quality control machinery of 
the secretory pathway. 
 
One of the most well-studied heat shock protein families is the Hsp70 (70 kDa heat 
shock protein) family. The chaperones within this family are highly conserved and are 
expressed in all cells and organelles (Awad et al., 2008). In humans there are at least 13 
identified members of the Hsp70 family (Vos et al., 2008), and in most other organisms 
multiple Hsp70 chaperones are also expressed (Meimaridou et al., 2009). The Hsp70 
proteins are involved in many diverse processes including prevention of aggregation 
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and promotion of folding of nascent proteins, un- and refolding of misfolded or 
aggregated proteins, and translocation of proteins across membranes (Mayer & Bukau, 
2005).  
 
Hsp70 chaperones recognise proteins that are not natively folded via short degenerate 
motifs consisting of a core of four to five residues enriched in hydrophobic amino acids 
and flanked by regions enriched in basic residues (Rudiger et al., 1997). Such motifs 
are common, and occur on average every 30-40 residues in most proteins. In the native 
folded protein, these motifs are usually buried in the hydrophobic core of the protein, 
but before and during folding, or upon denaturation, they are exposed and can be 
detected by the Hsp70 proteins, allowing the chaperones to distinguish between un- or 
misfolded proteins and their native counterparts (Mayer, 2013).  
 
Un- or misfolded substrates cycle between the free and Hsp70-bound states until all 
molecules have obtained their native conformation, but the exact mechanism by which 
folding is assisted by the chaperone is still unclear. Two mechanisms have been 
proposed: Either the Hsp70 acts by stabilising unfolded intermediates, keeping the free 
substrate concentration sufficiently low to prevent aggregation and allow correct 
folding, or it actively helps partially unfolding the substrates, yielding productive 
folding intermediates that then fold spontaneously into their native states (Slepenkov & 
Witt, 2002).  
 
The Hsp70 proteins contain an N-terminal nucleotide-binding domain (NBD) 
connected via a flexible linker to a C-terminal substrate-binding domain (SBD), which 
can be further subdivided into a β-sandwich domain, containing a substrate-binding 
pocket, and an α-helical lid (Mayer, 2013). The arrangement of the SBD changes 
depending on the nucleotide-state of the Hsp70. Binding of ATP to the NBD induces a 
conformational change in the SBD, which opens the lid from the substrate-binding 
pocket (Figure 5). In this state, substrates associate quickly with the chaperone, but the 
affinity is low. Binding of a substrate to the SBD stimulates the ATPase activity of the 
NBD, and hydrolysis of ATP induces a closing of the SBD lid over the substrate-
binding pocket and entrapment of the substrate. The signal arising from ATP hydrolysis 
is transmitted within the NBD through a hydrogen bond network, starting at the 
catalytic center and converging onto a conserved surface-exposed arginine at the 
interface between the NBD and the SBD (Vogel et al., 2006). 
 
The activity of Hsp70 proteins is regulated by co-chaperones and nucleotide exchange 
factors (NEFs) (Liberek et al., 1991). Co-chaperones from the Hsp40 (40 kDa heat 
shock protein) family, also known as the DnaJ family after the Escherichia coli Hsp40 
homologue DnaJ, bind to their Hsp70 partners and stimulate their ATPase activity, 
thereby assisting in keeping the unfolded protein associated with the Hsp70 chaperone 
(Cyr et al., 1992; Liberek et al., 1991). Another important function of Hsp40 proteins is 
to bind and deliver specific client proteins to Hsp70 chaperones (Cheetham & Caplan, 
1998). The interaction with Hsp70 is mediated by a J domain, containing a conserved 
histidine-proline-aspartate (HPD) motif known to be important for the co-chaperone 
function (Tsai & Douglas, 1996), but apart from this domain, the Hsp40 proteins 
exhibit large diversity. Three types of Hsp40 proteins have been distinguished 
(Cheetham & Caplan, 1998). Type I Hsp40 proteins show full domain conservation 
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with E. coli DnaJ; they contain, apart from the J domain, a Gly/Phe-rich region and a 
Cys-rich, zinc finger-like region. Type II Hsp40 proteins contain the J domain and the 
Gly/Phe-rich region, whereas type III Hsp40 proteins only share the J domain. There 
are more Hsp40 proteins than Hsp70 proteins, and the different properties of the 
various co-chaperones are believed to contribute to the versatile functions of the Hsp70 
family (Mayer & Bukau, 2005; Kampinga & Craig, 2010).  The nucleotide exchange 
factors are also important for the function of Hsp70 chaperones; they promote the 
release of ADP and the binding of ATP, and trigger thereby unloading of the bound 
substrate and recycling of the Hsp70 (Kampinga & Craig, 2010). Unlike the Hsp40 
proteins, which all share the J domain responsible for their regulation of Hsp70, four 
different types of NEFs, without any sequence similarity, have been identified. Some 
well-known NEFs are GrpE, which releases ATP from DnaK, the E. coli Hsp70 
homologue (Liberek et al., 1991), and the BAG family of NEFs, which interact with 
cytosolic Hsp70 proteins in eukaryotes (Hohfeld & Jentsch, 1997). 
 
 
 
Figure 5. The folding cycle of Hsp70 proteins. Unfolded or misfolded proteins are delivered to the open 
ATP-bound Hsp70 by a J domain protein. The J domain stimulates the ATPase activity of Hsp70, leading 
to a conformational change that traps the client protein in the substrate-binding domain (SBD) where 
folding is promoted. Nucleotide exchange factors stimulate the exchange of ADP to ATP in the 
nucleotide-binding domain (NBD), leading to an opening of the SBD and release of the folded client 
protein. (Adapted from Meimaridou et al., 2009.) 
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1.6.1 BiP and the ERdj proteins 
The mammalian ER orthologue of Hsp70 is BiP (immunoglobulin heavy-chain binding 
protein), also known as GRP78 (glucose-regulated protein of 78 kDa) (Shiu et al., 
1977; Haas & Wabl, 1983; Munro & Pelham, 1986). BiP is involved in many of the 
processes in the ER, including folding of nascent proteins (Lee et al., 1999), targeting 
misfolded proteins for degradation (Nishikawa et al., 2001), gating the translocon 
(Hamman et al., 1998), and regulating the unfolded protein response (Bertolotti et al., 
2000; Shen et al., 2002a). The different functions of BiP are regulated by the Hsp40 
homologues in the ER, the ER-localised DnaJ-containing (ERdj) proteins, of which at 
least seven have been identified to date (Figure 6) (Otero et al., 2010; Vembar et al., 
2010).  
 
The transmembrane protein ERdj1, also known as Mtj1, consists of a lumenal J domain 
and a cytosolic domain which interacts with translating ribosomes (Dudek et al., 2005). 
When BiP is not bound to the J domain, protein synthesis is inhibited, ensuring that BiP 
is always present when newly synthesised proteins enter the ER. 
ERdj2, or Sec63, is also a transmembrane protein with a lumenal J domain. It 
resembles yeast Sec63p, which plays a role in posttranslational translocation, but since 
mammalian translocation into the ER mainly occurs cotranslationally, its function is not 
clear (Meyer et al., 2000). 
The soluble ER protein ERdj3, also known as HEDJ, is upregulated during ER stress, 
and is suggested to assist the recruitment of BiP to nascent unfolded proteins or 
proteins unable to fold correctly (Shen & Hendershot, 2005). 
ERdj4 (MDG-1), anchored in the ER membrane via its uncleaved signal sequence and 
with the main part of the protein in the ER lumen, is upregulated during ER stress and 
has been suggested to be involved in protein folding or ER-associated degradation 
(Shen et al., 2002b). 
ERdj5, or JPDI, is a soluble protein with four thioredoxin-like domains in addition to 
the J domain (Cunnea et al., 2003; Hosoda et al., 2003). It has been suggested to reduce 
non-native disulfide bonds in BiP substrates and assist in their refolding, as well as 
targeting terminally misfolded proteins for elimination via ERAD (Dong et al., 2008; 
Oka et al., 2013). 
ERdj6, also known as P58IPK or DnaJC3, is mainly located in the ER lumen where it 
acts as a co-chaperone for BiP (Rutkowski et al., 2007; Petrova et al., 2008). It binds 
unfolded substrates via its tetratricopeptide repeat (TPR) domain, and is thought to 
assist in promoting protein folding in the ER lumen. 
ERdj7 consists of two transmembrane segments and a lumenal J domain. Its function 
remains to be determined, but it is not upregulated by ER stress, and reduced levels of 
ERdj7 do not induce the UPR, implying that it is not likely to play a role in protein 
folding or degradation (Zahedi et al., 2009). 
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Figure 6. The ERdj proteins. The ERdj proteins all share the J domain, but are otherwise different. 
ERdj1, ERdj2, ERdj4, and ERdj7 contain transmembrane segments, whereas ERdj3, ERdj5, and ERdj6 
are soluble. ERdj3 is a type I J domain protein with a Gly/Phe-rich region and a Cys-rich region, ERdj4 is 
a type II J domain proteins with a Gly/Phe-rich domain, and the remaining family members are type III J 
domain proteins. (Adapted from Otero et al., 2010.) 
 
 
1.7 P58IPK (ERdj6) 
P58IPK (58 kDa inhibitor of protein kinase) was first identified as an inhibitor of the 
cytosolic protein PKR (protein kinase RNA-activated) in influenza infection (Lee et al., 
1990; Barber et al., 1994). During viral infection, dsRNA-activated PKR 
phosphorylates the α-subunit of eIF2α, leading to protection of the cell through 
decreased synthesis of host and viral proteins. To prevent this, viruses recruit P58IPK to 
inactivate PKR, thereby permitting continued synthesis of viral proteins (Lee et al., 
1990). The P58IPK-mediated repression of PKR is, in turn, inhibited via binding of 
another protein, P52rIPK (52 kDa repressor of the inhibitor of protein kinase), to P58IPK 
(Gale et al., 1998). 
 
Later, the transcription of the P58IPK gene was shown to be induced in response to ER 
stress (Yan et al., 2002; van Huizen et al., 2003). P58IPK binds to the cytosolic part of 
PERK, one of the key regulators of the UPR, inhibiting PERK-mediated 
phosphorylation of eIF2α (Yan et al., 2002). Thereby P58IPK has been suggested to act 
as a component of a negative feedback loop, used to attenuate eIF2α signalling at the 
later stages of the UPR, when protein synthesis is needed. 
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The importance of P58IPK for regulation of the stress response was demonstrated by 
knockout studies in mice (Ladiges et al., 2005). After deletion of the P58IPK gene, mice 
exhibited a diabetic phenotype, with glucosuria, hyperglycemia, and hypoinsulinemia, 
as well as increased apoptosis of pancreatic β-cells. These secretory cells are likely 
particularly susceptible to accumulation of unfolded proteins and ER stress, and the 
results are consistent with an important role for P58IPK in the unfolded protein response. 
 
Studies of mouse embryonic fibroblasts revealed a reduced ability to cope with 
misfolded proteins in the absence of P58IPK, and based on these results a role for P58IPK 
in protein processing and maturation was proposed (Rutkowski et al., 2007). Since the 
major site of protein folding is the ER, this suggested that P58IPK is located in the ER 
lumen rather than, as was previously thought, peripheral to the ER membrane. 
Reexamination of the localisation of P58IPK then indeed showed that the protein is 
translocated into the ER directed by a cleavable N-terminal signal sequence, and that it 
is mainly located to the lumen, both in stressed and non-stressed cells. However, 
inefficiency of the signal sequence has been suggested to result in a small fraction of 
the protein not being translocated into the ER, but being able to perform its cytosolic 
interactions with PKR and PERK.  
 
P58IPK belongs to the DnaJ family or Hsp40 family of proteins that interact with 
chaperones of the Hsp70 type. This, in combination with its localisation to the ER 
lumen, gave rise to the hypothesis that P58IPK could interact with the Hsp70 homologue 
of the ER, BiP (Rutkowski et al., 2007). The interaction between P58IPK and BiP was 
proven by immunoprecipitation; BiP from liver microsomes co-purified P58IPK, and 
vice versa. This has led to the suggestion that P58IPK acts as a co-chaperone for BiP. 
Further, it has also been demonstrated that P58IPK can make direct interactions with 
unfolded protein substrates (Tao et al., 2010). Although the mechanism of this co-
chaperone function is still not completely clear, P58IPK has been proposed to bind an 
unfolded protein substrate, stabilise it, and then, after binding to BiP, deliver the 
substrate to the chaperone.  
 
In P58IPK, the N-terminal ER translocation signal sequence is followed by nine 
tetratricopeptide repeats and a C-terminal J domain. Tetratricopeptide repeats are 
motifs of 34 amino acids with a degenerate consensus sequence defined by a pattern of 
small and large hydrophobic residues (Zeytuni & Zarivach, 2012). When comparing 
TPR motifs from functionally unrelated proteins, conservation is limited to eight 
consensus residues at positions 4, 7, 8, 11, 20, 24, 27, and 32, whereas functionally 
equivalent TPR motifs also can exhibit conservation outside of these residues (Blatch 
& Lassle, 1999). The TPR motif adopts a helix-turn-helix fold. Often, proteins contain 
tandem arrays of up to 16 TPR motifs, and when multiple TPR motifs are connected, 
they form a series of antiparallel α-helices. The angle between two adjacent helices is 
then such that a curvature is created, resulting in one concave and one convex surface 
(Zeytuni & Zarivach, 2012). TPR motifs are known to participate in protein-protein 
interactions in a variety of cellular processes. The ligand bound by the TPR can adopt 
an α-helical or extended coil conformation, or a combination of both. 
 
The J domain, conserved between members of the Hsp40 family, is composed of two 
shorter and two longer α-helices. In the turn between the two longer helices is located 
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the HPD motif; a motif known to be important for the Hsp40-mediated stimulation of 
the ATPase activity of Hsp70 proteins. The positioning of the J domain at the C-
terminus of P58IPK is unusual; more commonly it is found at the N-terminus of proteins 
(Cyr et al., 1994). 
 
To date, no structural information is available on P58IPK in complex with any of its 
interaction partners. However, various studies have localised the different interactions 
to specific parts of the protein. With respect to the BiP interaction, it has been shown by 
co-immunoprecipitation experiments that the J domain is important; a P58IPK construct 
without the J domain did not interact with BiP (Rutkowski et al., 2007). Yeast two-
hybrid experiments have suggested that the interaction between P58IPK and PKR 
involves TPR6 (Gale et al., 1996; Tang et al., 1996), and TPR7 has been proposed to 
be the binding site for P52rIPK (Gale et al., 2002).  
  23
2 AIM OF THE THESIS 
 
The overall aim of this thesis project was to gain a deeper understanding of different 
aspects of the early secretory pathway. Members of three different protein-protein 
complexes have been structurally characterised by X-ray crystallography and NMR 
spectroscopy, and further investigations have been performed. 
 
The specific aims of this project have been: 
 
- To determine the structure of MCFD2 and to give insights into its Ca2+-
dependent interaction with ERGIC-53.  
 
- To clarify the mechanism by which mutations in MCFD2 cause the blood 
coagulation factor deficiency disorder F5F8D. 
 
- To determine the structure of Erv41 and to increase the understanding of its role 
in the cell. 
 
- To determine the structure of P58IPK and to further investigate its functions. 
 
-  To investigate the interaction between P58IPK and BiP in order to give insights 
into how co-chaperones regulate the different functions of the chaperone. 
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3 RESULTS AND DISCUSSION 
 
3.1 NMR studies and biophysical characterisation of MCFD2 (Paper I) 
When the work described in paper I was initiated, the importance of MCFD2 for 
efficient transport of the blood coagulation factors V and VIII had been clearly 
established, but its precise role in these processes still remained elusive. Ca2+ had been 
shown to be important for complex-formation with ERGIC-53, but little structural 
information was available to explain the mechanism behind this observation. In order to 
increase the understanding of the function of MCFD2, its interactions with ERGIC-53, 
and the mechanism by which mutations in the protein cause disease, the initial aim was 
to determine the structure of human MCFD2 by X-ray crystallography. However, 
despite extensive crystallisation screening, no crystals could be produced. Instead, 
NMR studies to determine the structure of the wild-type protein and to characterise 
several mutations that are found in patients with the bleeding disorder F5F8D, were 
performed in collaboration with Professor Torleif Härd at the Swedish NMR Centre at 
the University of Gothenburg. 
 
 
3.1.1 NMR spectroscopy and structure determination 
An MCFD2 construct encoding the full mature protein (residues 27-146), excluding the 
ER-localisation signal sequence, was used to produce native and isotope-labelled (15N 
and 15N/13C) protein in E. coli for the NMR experiments. Initial measurements were 
performed in Ca2+-free phosphate buffer, resulting in spectra with the characteristics of 
an unfolded protein, with no evidence of secondary structure or of a hydrophobic core. 
In the 15N-HSQC spectrum, this is seen as poorly resolved amide resonances in the 
random coil region, around 8.0 ppm (Figure 7A). Exchange into MES buffer and 
addition of Ca2+ ions resulted in a markedly different spectrum, showing a number of 
the well-dispersed peaks associated with presence of secondary and tertiary structure, 
although some disorder still remains (Figure 7B). Binding of Ca2+ causes functionally 
important conformational changes in many other EF-hand proteins (Yap et al., 1999), 
but few are entirely dependent on Ca2+ for folding, and the complete loss of secondary 
structure observed for MCFD2 in the absence of Ca2+ is unusual.  
 
Because of the apparent Ca2+-dependent folding of MCFD2, all NMR spectra used for 
the structure calculations were recorded in the presence of CaCl2. Several 
multidimensional heteronuclear NMR spectra were recorded to obtain the resonance 
assignments of 1H, 13C, and 15N nuclei for the structure calculation. Despite the 
observed partial disorder in MCFD2, nearly complete backbone assignments were 
achieved, with the exception of a small number of residues in the unstructured region. 
Side-chain resonance assignment was almost complete in the ordered region of the 
structure, whereas over-crowding of the random coil regions made the assignment of 
several side-chains in the disordered regions impossible. A total of 2142 distance 
restraints were identified by nuclear Overhauser enhancement (NOE) assignments. 
Very few medium- or long-range restraints could be localised to the N-terminal 
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residues 27-66 and residues 102-112, localising the disordered parts of the protein to 
these regions. Based on the assignments, secondary structure elements were defined 
and the final ensemble of MCFD2 structures was calculated by automated iterative 
NOE assignment and structure calculation by simulated annealing.  
 
 
 
Figure 7. NMR spectra of MCFD2. (A) The 15N-HSQC spectrum recorded in the absence of Ca2+. (B) 
The 15N-HSQC spectrum recorded after addition of 10 mM CaCl2, with the assignments indicated for all 
backbone NH resonances in the ordered region.  
 
 
3.1.2 Overall structure of MCFD2 
The disordered N-terminus of MCFD2, extending from residue 27 to residue 69, is 
followed by four α-helices and two short β-strands forming two EF-hand motifs (Figure 
8). These EF hands are packed against each other to form one single domain, with a 
fold similar to that of other EF-hand proteins such as parvalbumin and S100 proteins 
(Lewit-Bentley & Rety, 2000). As in other EF hands, one Ca2+ ion is coordinated in the 
loop connecting the two helices of each motif. 
 
 
Figure 8. Overall NMR structure of MCFD2. (A) The ensemble of the 20 lowest-energy structures, 
showing the complete structure including the disordered N-terminal part. (B) The ordered region of 
MCFD2, residues 67-146 (PDB ID 2VRG).  
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Two features that distinguish MCFD2 from its structural homologues, the closest of 
which is the C-terminal domain of calmodulin with an RMSD (Root Mean Square 
Deviation) of 1.9 Å over 57 residues, are the significantly longer loop connecting the 
two EF-hand motifs, and the second helix, which is more bent and packed more tightly 
into the structure than in homologous structures. Backbone amide resonance 
broadening, indicative of conformational interconversions on the microsecond to 
millisecond time scales, was observed for residues in this region, suggesting that it 
might be able to adopt different conformations. This was later confirmed by the crystal 
structure of the complex between MCFD2 and ERGIC-53, which revealed 
conformational changes in this part of MCFD2 upon complex formation (Wigren et al., 
2010). In the complex, the second helix, which is bent in the NMR structure, is 
straightened, and the subsequent helix is tilted by approximately 20. 
 
Another interesting feature of MCFD2 is the disordered N-terminus. This region shows 
very little sequence identity to most other proteins, but is highly conserved in 
orthologues of MCFD2, implying a potential role in the function of the protein. One 
hypothesis is that this unstructured part is involved in binding of ERGIC-53 or the 
cargo proteins factor V and factor VIII, and that it could adopt a more ordered 
conformation upon interaction.  
 
 
3.1.3 NMR and CD studies of F5F8D causing mutants 
Several mutations in MCFD2 have been linked to disease in patients with the bleeding 
disorder F5F8D. At the time of this study, it had been demonstrated that two of these 
mutations, resulting in single amino acid substitutions in the second EF-hand motif, 
abolished interaction between MCFD2 and ERGIC-53 in vivo (Zhang et al., 2003). 
This was suggested to imply Ca2+-binding of MCFD2 to be required for formation of 
the transporter complex, but no structural information was available to support this 
theory.  
 
The disease-causing mutations D129E and I136T, as well as the I136V mutation which 
causes reduced, but not lost, interaction with ERGIC-53 (Zhang et al., 2003), were 
introduced into MCFD2 by site-directed mutagenesis. 15N-labelled mutated proteins 
were expressed, purified, and used for circular dichroism (CD) spectroscopy and 
collection of 15N-HSQC spectra. NMR data revealed that the two disease-causing 
mutations D129E and I136T prevent correct folding of the protein. 15N-HSQC spectra 
recorded for these mutants are markedly different than the wild-type spectrum, showing 
the clustered peaks characteristic of an unfolded protein (Figure 9A and B). Despite 
being recorded in the presence of Ca2+, these mutant spectra resemble that of the Ca2+-
free unfolded form of MCFD2. The I136V mutant, on the other hand, retains its ability 
to fold; the 15N-HSQC spectrum recorded for this mutant is similar to that of the wild-
type protein, but shows changes in the resonances of several residues, particularly 
Gly134 and Leu88 (Figure 9C). CD spectroscopy analysis confirmed the lower 
secondary structure content of the disease-causing mutants, again giving spectra similar 
to that obtained for the unfolded apo-form of MCFD2, while the spectrum of the I136V 
mutant is closer to that of the wild-type protein (Figure 9D).  
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Figure 9. 15N-HSQC spectra of the MCFD2 mutants, recorded in the presence of Ca2+. (A) D129E (B) 
I136T (C) I136V (D) CD spectra of the D129E (broken grey line), I136T (continuous grey line), I136V 
(broken black line), together with wild-type MCFD2 (continuous black line). All spectra were recorded in 
the presence of Ca2+. 
 
 
Both mutated residues are positioned in the second EF-hand motif of MCFD2 (Figure 
10). Asp129 is the first residue of the Ca2+-binding consensus sequence of the EF-hand 
loop. The aspartate at this position is highly conserved; it binds Ca2+ and contributes to 
the structure of the loop by forming several intraloop hydrogen bonds (Gifford et al., 
2007). Substitution at this position prevents the correct formation of the EF hand, and 
disrupts thereby the core structure of the protein. Ile136 is also located to the second EF 
hand, but it is not involved in binding of Ca2+. There is no complete conservation of the 
residue at this position, but it is always hydrophobic. In wild-type MCFD2, the side-
chain of this residue faces away from the Ca2+-binding site and is packed into the 
hydrophobic core of the protein. Introducing a polar residue, such as threonine, at this 
position would most likely disturb the packing of the hydrophobic core, resulting in a 
disordered protein, whereas the effect of mutation into another hydrophobic residue of 
similar size would be less dramatic. Our results indicated that mutation of the studied 
residues causes inefficient coagulation factor transport and F5F8D via complete 
disruption of the structure of MCFD2 resulting in its inability to interact with ERGIC-
53. This suggested that the mutations are not necessarily located at the site for 
interaction with ERGIC-53, a suggestion that was later confirmed by the ERGIC-
53/MCFD2 complex structure (Wigren et al., 2010). 
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Figure 10. The positions of the mutated residues in the second EF-hand loop of MCFD2. Asp129 is 
involved in coordination of Ca2+ and Ile136 is packed into the hydrophobic core of the protein. 
 
 
In summary, the first structure of human MCFD2 was determined and a detailed 
description of the protein was provided. The results demonstrated that the protein is 
unfolded in the absence of Ca2+ ions and that, even in the presence of Ca2+, the N-
terminal part of the protein remains disordered. This Ca2+-dependent folding of 
MCFD2 gave a first insight into the function of Ca2+ as an allosteric activator of the 
protein and its interaction with ERGIC-53. The studies of disease-causing mutations 
enabled us to explain for the first time how these alterations of the protein cause 
inefficient coagulation factor transport in patients. Our results emphasise the 
importance of the intact EF-hand motifs for the structural stability and cargo-
transporting function of MCFD2, and suggest that disruption of the ERGIC-53/MCFD2 
interaction is the mechanism by which the studied mutants cause F5F8D. 
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3.2 Structural studies of Erv41p (Papers II and III) 
Erv41p and its complex partner Erv46p are highly conserved throughout eukaryotes, 
implying that they play an important role in the cell. They have been linked to transport 
and processing of glycoproteins, and the human proteins have recently been implicated 
in the progression of three different types of cancers, but when the study described in 
papers II and III was initiated, little was known about the structure of any of these 
proteins or their precise functions. In order to provide a better understanding of the 
biological role of these proteins and enable future structure-function experiments and 
interaction studies, we have determined the structure of yeast Erv41p and initiated a 
detailed analysis of the properties of the protein. 
 
 
3.2.1 Protein production, crystallisation and structure determination 
Based on the previously reported domain topology and secondary structure prediction, 
multiple constructs of ERGIC2 (human Erv41) were designed and cloned for 
expression in E. coli. However, despite extensive screening for suitable expression and 
lysis conditions, only minute amounts of soluble protein could be obtained. In order to 
increase the chances of achieving expression of soluble protein, we decided to expand 
our study to include the Saccharomyces cerevisiae homologue Erv41p, which, coming 
from a lower eukaryote, could be expected to be more easily expressed in a prokaryotic 
host. Although several of the designed constructs of the yeast protein could be 
overexpressed, solubility was still a major problem. We went on to test different 
expression systems; expression of the human protein in mammalian cells yielded low 
amounts of protein, but only when the yeast protein was expressed in insect cells and 
secreted to the medium were good results obtained. With this setup, we were able to 
express the longest designed construct, Erv41p_LD, spanning the full lumenal domain 
of Erv41p (Figure 11), and we could purify protein of sufficient amounts and quality 
for crystallisation trials, with a final yield of 1-5 mg of protein per litre culture medium. 
 
 
Figure 11. Graphical representation of full-length S. cerevisiae Erv41p with the membrane topology 
indicated. The lumenal domain is shown in dark grey, the transmembrane regions in light grey and the 
cytosolic tails in white. The construct of the lumenal domain used for crystallisation, Erv41p_LD, is 
shown below. 
 
 
Initial crystallisation hits were established using commercial sparse-matrix screens and 
after optimisation of the conditions, crystals that diffracted to 2.0 Å resolution were 
obtained. Since no structure of any sufficiently homologous protein was available, we 
needed to determine phases for structure solution experimentally. A large number of 
heavy atom compounds were tested for soaking, and both soaking time and 
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concentration were optimised in order to find a condition giving an anomalous signal 
without destroying the crystal. The diffraction of the native crystals was already 
unreliable, and this problem was only amplified by soaking in heavy atoms; a large 
number of derivative crystals were screened on the beamline before we could collect a 
useful dataset. Finally, the structure was solved by single-wavelength anomalous 
diffraction (SAD) phasing, using an Yb3+ derivative with one heavy atom site per 
asymmetric unit. The Yb3+-derivatised crystals were not isomorphous with the native 
crystals, and the inclusion of isomorphous replacement to improve phasing was 
therefore not possible. A model of the core of the protein could be built based on the 
maps from SAD phasing, and was then used for molecular replacement into the higher-
resolution native dataset, allowing refinement of the structure to 2.0 Å resolution. 
 
 
3.2.2 Overall structure of Erv41p 
The lumenal part of Erv41p comprises one single domain composed of 14 β-strands 
and 5 short α-helical segments (Figure 12). The main body of the domain is made up of 
two twisted β-sheets of mixed character, one with eight strands and one with six, 
packed against each other to form a β-sandwich with both convex and concave regions. 
 
 
 
 
Figure 12. Overall structure of the lumenal domain of Erv41p. Cartoon representation of the structure 
shaded according to secondary structure, with β-strands in light grey and α-helices in dark grey (PDB ID 
3ZLC). (A) The crystal structure combined with a schematic to show the position of the lumenal domain 
in the full protein. (B) Side view of the β-sandwich, related to the view in A by 90 rotation. 
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The N- and C-terminal ends of the structure, which would be very close to the 
membrane in the full-length protein, form two β-strands protruding from the main β-
sandwich, which would function to separate it from the membrane. The two termini are 
positioned close together, suggesting that the two transmembrane helices attached to 
these ends in the full-length protein would also be situated next to each other in the 
membrane. On the opposite end of the β-sandwich, the helical segments and several 
long loops are clustered. This region is likely flexible, considering that several of the 
loops could not be completely modelled and that B-factors were higher here than in 
other parts of the structure.  
 
 
3.2.3 Potential interaction sites 
Erv41p is known to be part of a large complex in the cell, and its interactions with other 
proteins of this complex are most likely of importance to its function. In order to find 
out more about the character of such interactions, and to find potential interaction sites, 
we analysed the surface of the protein. 
 
Analysis of the hydrophobic surface of the lumenal domain of Erv41p shows that a 
number of hydrophobic patches are distributed all over the surface, but none of these 
stands out as a clear site for protein-protein interactions. In contrast, the electrostatic 
surface potential reveals a dominant negatively charged area covering one entire face of 
the β-sandwich (Figure 13A and B). Due to the curved shape of the β-sandwich, this 
negative patch coincides with a broad shallow groove stretching across the protein. 
Furthermore, this region harbours a number of residues that are highly conserved across 
eukaryotic species (Figure 13C and D). Together, these structural features suggest that 
this could indeed be a region of physiological importance, most likely as a binding site 
for an interaction partner or ligand. 
 
An additional cluster of conserved residues can be identified in the membrane-proximal 
region of the lumenal domain. The same region is also identified by the meta-PPISP 
server (Qin & Zhou, 2007) as the most likely site for protein-protein interactions in the 
structure (Figure 13E, F, and G). This area is involved in crystal-packing interactions 
between the two monomers seen in the asymmetric unit of our crystals. Although this 
interaction is unlikely to be physiological, since both size-exclusion chromatography 
and dynamic light scattering show the protein to be a monomer, it strengthens the 
hypothesis that this area is capable of participating in protein-protein interactions.  
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Figure 13. Surface properties of Erv41p. (A and B) Electrostatic representation of Erv41p showing 
negative surface potential in red and positive surface potential in blue. The two views are related by 180 
rotation around a vertical axis and correspond to the two faces of the β-sandwich. (C and D) 
Representation of the evolutionary conservation of Erv41. The sequence of S. cerevisiae Erv41p was 
aligned with homologue sequences from Homo sapiens, Bos taurus, Mus musculus, Danio rerio, and 
Saccharomyces pombe. The surface of Erv41p is coloured according to residue conservation among these 
six organisms, with invariant residues in shown red, residues that are identical in five organisms shown in 
orange, and residues conserved in four organisms shown in yellow. The two views of the protein are the 
same as those in A and B, respectively. (E, F, and G) Predicted protein-protein interaction sites. The 
surface residues of Erv41p are coloured according to their relative probability of participating in protein-
protein interactions, as calculated by the meta-PPISP server, from red indicating the highest probability to 
blue indicating the lowest probability. The three views are related by sequential 90 rotations, with E and 
G corresponding to the views in A and B, respectively. 
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3.2.4 Similarity to other structures 
Since the role of Erv41p in the cell is not fully understood, we were hoping that 
structural similarity to proteins of known function could give some hints towards its 
function. However, the sequence homology of Erv41p to other proteins with known 
structure is low, and neither are there any close structural homologues. Two servers 
were used to identify structural homologues in the Protein Data Bank. Only very weak 
matches were found, and different results were obtained with each server; the Dali 
server (Holm & Rosenström, 2010) identified acid-sensing ion channels as the top hits, 
whereas the PDBeFold server (Krissinel & Henrick, 2004) found a carbohydrate-
binding module as the closest structural homologue.  
 
The complex between Erv41p and Erv46p has been suggested to play a role in 
glycoprotein processing and transport; it has been reported to interact with the ER 
glucosidase II, Rot2p, and strains lacking a cycling Erv41p-Erv46p complex display a 
mild glycoprotein processing defect (Welsh et al., 2006). In the light of this, the β-
sandwich structure of Erv41p is interesting, since a number of β-sandwich proteins 
have carbohydrate-binding properties. However, the structural homology to these 
proteins is limited and no conserved carbohydrate-binding motifs can be identified in 
Erv41p. 
 
 
In conclusion, we determined the first structure of Erv41p or any of its homologues, 
and provided a detailed analysis of the structural features of the protein. The protein 
adopts a β-sandwich structure with only limited structural homology to other proteins. 
Two potential binding sites for interaction partners or ligands could be identified by 
analysis of the surface properties of the protein. The structure of Erv41p has provided a 
new level of knowledge about the protein, and will facilitate further, more detailed 
investigations into its function. 
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3.3 Functional studies of Erv41p and Erv46p 
With the structure of Erv41p as a starting point, our aim was to further investigate the 
role of the protein in the cell, and its interactions with binding partners and ligands. In 
order to do this we have also expressed S. cerevisiae Erv46p for structure determination 
on its own, functional studies, studies of the interaction with Erv41p, and ultimately 
complex structure determination. With the suggested role of the Erv41p-Erv46p 
complex in glycoprotein processing in mind, we have investigated whether any of the 
proteins interacts directly with glycans. Furthermore, we have looked into the 
possibility that Ca2+ could stabilise the Erv41p structure. 
 
 
3.3.1 Expression and crystallisation of Erv46p 
ERGIC3 (human Erv46) was initially cloned for expression in E. coli. Several 
constructs could be overexpressed, but most of them not in soluble form, and only one 
very short construct could be purified. In analogy with Erv41p, however, the lumenal 
domain of yeast Erv46p could be expressed in insect cells and secreted to the medium 
in soluble form, and could be purified to homogeneity. The purified protein, both with 
and without the secretion signal sequence and His-tag included in the expression 
construct, has been used for crystallisation screening. An initial crystallisation 
condition has been established, and the very small crystals have been tested at a 
synchrotron beamline. No protein diffraction was observed, most likely due to the 
limited size of the crystals, but the crystals appeared not to be salt and optimisation of 
this crystallisation condition, as well as continued screening, is ongoing. 
 
 
3.3.2 Thermofluor studies of the potential role of Erv41p in glycan-binding  
The Erv41p-Erv46p complex has been strongly suggested to play a role in glycoprotein 
processing or transport, and the β-sandwich structure of Erv41p shows some similarity 
to other glycan-binding proteins in the early secretory pathway, e.g. ERGIC-53. No 
conserved sugar-binding site could be identified from the structure of Erv41p, but these 
sites are often difficult to identify since they are shallow and very variable. An obvious 
starting point for our functional studies was therefore to determine whether Erv41p or 
Erv46p bind to sugars, and if so, with what specificity. 
 
In order to further investigate the proposed glycoprotein-interacting roles of Erv41p 
and Erv46p we initially performed Thermofluor ligand screens using a limited number 
of low-complexity carbohydrates. With Thermofluor, binding of a ligand and 
concomitant stabilisation of a protein can be detected as a shift in the melting 
temperature of the protein. A fluorescent dye that binds to hydrophobic patches is 
added to the protein and the temperature of the sample is gradually increased. As the 
protein is denatured, the fluorescence signal increases and a melting temperature can be 
determined. If a ligand that stabilises the protein is added, the melting temperature will 
increase and a thermal shift can be determined. No clear indication of interaction could 
be detected in these experiments, perhaps not surprisingly, since the glycan moieties of 
glycoproteins in a eukaryotic cell are substantially more complex than those tested.  
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3.3.3 Potential Ca2+-binding of Erv41p 
Although no carbohydrate ligands for Erv41p could be detected in our Thermofluor 
screen, we did make another interesting observation. Screening was performed both in 
the presence and absence of Ca2+, and addition of Ca2+ was observed to result in a 
thermal shift of approximately 8 C, suggesting that the ion had a stabilising effect on 
the protein. In the ER and the Golgi the Ca2+ concentration is known to be much higher 
than in the cytosol, whereas Ca2+ levels are below the detection limit in the ERGIC. 
These variations are believed to be of importance for the functions of the secretory 
pathway, and many of the proteins localised to these compartments are binding Ca2+. 
This could be the case also for Erv41p; Ca2+ could for example be necessary to form a 
ligand-binding site. 
 
To further investigate how Ca2+ affects the structure of Erv41p, soaking experiments 
with different concentrations of Ca2+ and different soaking times, as well as co-
crystallisation using the condition established for the native protein, were performed. In 
case the packing in the current crystal form would prevent binding of Ca2+, we also 
tried screening for new crystallisation conditions in presence of Ca2+. Data could be 
collected to 2-3 Å resolution from both soaked crystals and crystals from co-
crystallisation, but no density for Ca2+ ions could be observed, and no conformational 
changes compared to the native protein indicated any Ca2+-induced effects on the 
structure. 
 
 
3.3.4 Glycan array screen with Erv41p and Erv46p 
As the range of glycans tested in our Thermofluor screens was very limited, a glycan 
array screen was performed in collaboration with the Consortium for Functional 
Glycomics with the aim to significantly expand the carbohydrate-space investigated. In 
this screen (Mammalian Printed Array version 5.1), more than 600 natural and 
synthetic mammalian glycans printed onto a microarray were tested for binding to the 
lumenal domains of both Erv41p and Erv46p. An anti-His antibody was used to detect 
His-tagged protein bound to glycans. Since many carbohydrate-binding β-sandwich 
proteins are dependent on Ca2+ for their function, and we had some evidence that 
Erv41p might be binding Ca2+ (see above), screening was performed both in the 
presence and absence of Ca2+.  
 
The results of this assay were classed by the Consortium for Functional Glycomics as 
negative; no carbohydrates were identified as potential ligands for either Erv41p 
(Figure 14A and B) or Erv46p (Figure 14C and D). The signal was very low for all 
tested glycans. In the case of Erv46p, some glycans did seem to give rise to a signal 
higher than the background, and they reproducibly did so both in the presence and 
absence of Ca2+, but also for these the signals were much lower than could be expected 
from a true binder. Signals in this range have been classed as positive for other proteins, 
but then there have been structural correlations between the hit glycans, supporting 
their binding to the protein. This was not the case for Erv46p; the top glycans were 
varied (Figure 14E), and there were related structures on the array that did not bind.   
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Figure 14. Glycan array screen results for Erv41p and Erv46p. Glycan binding was tested using the 
Mammalian Printed Array version 5.1 according to the standard procedure of the Consortium for 
Functional Glycomics. Error bars represent standard error of the mean from four measurements. (A) 
Erv41p analysed in the absence of Ca2+. (B) Erv41p analysed in the presence of Ca2+. (C) Erv46p 
analysed in the absence of Ca2+. (D) Erv46p analysed in the presence of Ca2+. (E) The top hits from the 
Erv46p screens.  
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Despite the suggested roles of these proteins in glycoprotein processing or transport it is 
of course possible that they do not in fact interact with carbohydrates. However, even if 
the proteins indeed bind glycan moieties in the cell, there could be several reasons for 
the negative results obtained in this in vitro assay. Negative results could be due to low 
binding affinity or inactive protein. In addition, technical problems, such as problems 
of the anti-His antibody to detect our proteins, could be a reason for the absence of 
binding. One potential problem with this assay was that our yeast proteins, which were 
the only homologues that we could express and purify in sufficient amounts, were 
screened against mammalian glycans, since no equivalent yeast array was available. 
Already the human glycome is not fully covered by the screen, and is possible that 
screening against a set of yeast glycans would give a different result. However, many of 
the samples for which positive hits have been found from this screen have been non-
mammalian. Furthermore, the Erv41p-Erv46p complex has been suggested to interact 
with glycoproteins, and not necessarily isolated sugars, and it is possible that a 
combination of a glycan moiety and a protein determinant is necessary for interaction. 
In addition, it is conceivable that only the complex of Erv41p and Erv46p, and not the 
isolated proteins, binds to glycans, and further screening of carbohydrate-binding to the 
complex would therefore be interesting. 
 
 
In summary, Thermofluor measurements suggest that Ca2+ ions stabilise Erv41p. No 
obvious binding site for Ca2+ can be identified based on our structure of Erv41p, but 
Ca2+-binding sites often include a combination of acidic side-chains and main-chain 
atoms (Kretsinger, 1976), and can be difficult to identify or predict from sequences or 
metal-free structures. If Ca2+ would indeed be binding to the protein, it would not be 
surprising, considering that many other glycoprotein-interacting β-sandwich proteins of 
the secretory pathway depend on Ca2+ for their function. Based on the structural 
similarity of Erv41p to such carbohydrate-binding proteins, we performed a screen for 
binding to a large number of glycans, but none of the carbohydrates tested showed 
binding to either Erv41p or Erv46p.     
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3.4 Structural studies of human P58IPK (Paper IV) 
P58IPK has been shown to play multiple roles in the cell. It is involved in influenza 
infection via its inhibition of PKR, it inhibits PERK at the later stages of the unfolded 
protein response and it interacts with BiP, supposedly as a co-chaperone delivering 
unfolded proteins. Although these interactions have been mapped to different regions of 
P58IPK, the lack of structural knowledge has made it difficult to fully understand the 
mechanisms behind them. The aim of the work described in paper IV was to determine 
the structure of human P58IPK in order to gain further insight into its functions in the 
cell, and to provide a basis for studies of the interactions with its binding partners. 
 
 
3.4.1 Protein production, crystallisation and structure determination 
Multiple constructs of human P58IPK were cloned for expression in E. coli. The longest 
soluble construct comprised the mature protein up to the end of the J domain, without 
the N-terminal signal sequence and the 43 C-terminal residues, which were predicted to 
be unstructured. The expression construct included an N-terminal His-tag, and protein 
both with and without this tag was used for screening for crystallisation conditions. 
Extensive screening revealed only one condition yielding crystals, and this only when 
protein with the intact His-tag was used. Despite optimisation efforts and screening of a 
large number of crystals at the synchrotron, no resolution higher than 4-5 Å could be 
obtained from any of these native crystals.  
 
With the hope that a homologous protein would give better crystals, P58IPK from 
different organisms (Danio rerio, Drosophila melanogaster, and Caenorhabditis 
elegans) were cloned, expressed and purified and used for crystallisation screening. 
However, none of the constructs produced crystals in any of the crystallisation screens. 
Some spherulites were obtained, but before these were optimised we were able to solve 
the structure of the human protein, and the work on the homologues was thus not 
pursued. 
 
At the time, no structure of homology high enough to be used as a model for molecular 
replacement was available. Therefore, selenomethionine-substituted human P58IPK was 
produced for phasing purposes. This derivatised protein turned out to yield significantly 
better crystals than those previously obtained from the native protein, and data was 
collected at the Se-edge to 3.2 Å resolution in space group P312. At approximately the 
same time, a partial structure of mouse P58IPK was published by another group (Tao et 
al., 2010), allowing us to use a combination of molecular replacement and single-
wavelength anomalous diffraction to solve the structure. Using the optimised condition 
identified for the selenomethionine-containing crystals, we finally found that native 
protein, without the His-tag, yielded crystals that were similar, but that diffracted in 
space group H32. One of these crystals finally allowed us to collect a dataset used to 
refine the structure to 3.0 Å. The structure is very similar in the two crystal forms, with 
an RMSD of 0.8 Å.  
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3.4.2 Overall structure of P58IPK 
P58IPK adopts an elongated shape; the protein is approximately 120 Å long but only 20-
50 Å wide (Figure 15). The N-terminal TPR domain consists of 19 α-helices arranged 
into nine TPR motifs. These are further divided into three groups of three TPR motifs 
each. Tandem arrays of TPR motifs often adopt a super-helix structure of antiparallel α-
helices (Zeytuni & Zarivach, 2012), but in P58IPK two longer helices create the three 
subdomains, each with one concave and one convex surface.  
 
The first secondary structure element of the J domain is a turn of a helix (helix I) 
separated from the TPR domain by three amino acid residues adopting an extended 
conformation. The short helical segment is followed by a long loop, and together they 
act as a linker between the TPR domain and the remainder of the J domain, adding 
flexibility to the protein. The main body of the J domain is composed of two 
antiparallel α-helices (helix II and helix III) separated by a short loop region harbouring 
the conserved histidine-proline-aspartate (HPD) motif. Another turn of a helix (helix 
IV) could be built, but the last residues of the crystallised construct were not visible in 
the electron density, indicating that the C-terminus of P58IPK is unstructured.  
 
 
 
 
Figure 15. Overall structure of human P58IPK. (PDB ID 2Y4T). 
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3.4.3 Comparison to the TPR domain of mouse P58IPK 
The structure of the TPR domain of mouse P58IPK (PDB ID 3IEG) (Tao et al., 2010) 
was determined shortly before we could solve the structure of the full-length human 
protein. Despite a high sequence identity between the two homologues, the structures of 
the TPR domains differ (Figure 16). The long helices connecting subdomain I and II, 
and II and III, are bent and rotated in the human structure. This results in a more curved 
shape of the human protein, with the subdomains closer together. Whether this 
structural difference is a true physiological feature is not easy to say. Considering the 
high sequence identity, it is perhaps less likely that the structure of the two proteins are 
indeed different. The observed differences could instead be explained by the absence of 
the J domain in the mouse structure; it is possible that the conformation of the TPR 
domain is altered when a J domain is attached. Yet another explanation for the 
differences could be that they arise from differences in crystal packing. The structural 
differences between the two TPR domains do however tell us that there is an inherent 
flexibility in the structure, a flexibility that is likely important for its function in binding 
different interaction partners.  
 
 
 
Figure 16. Comparison of human and mouse P58IPK TPR domains. Superposition of the human P58IPK 
structure (dark grey) and the structure of the TPR domain of mouse P58IPK (light grey). The structural 
alignment was based on TPR subdomain II.  
 
 
3.4.4 Binding sites for interaction partners 
The HPD motif in the J domain is conserved among Hsp40 proteins and is commonly 
shown to be involved in interactions with Hsp70 chaperones, as has previously been 
shown to be the case with P58IPK and BiP (Petrova et al., 2008). In human P58IPK, as in 
other J domain proteins, the HPD motif is positioned in the loop between the two long 
helices II and III of the J domain (Figure 17A). The motif is positioned at the edge of 
the elongated protein, readily accessible for interaction with BiP. For other Hsp40-
Hsp70 pairs, it has been suggested that, in addition to the HPD motif, helix II, and to a 
lesser extent helix III and the loop between these two helices, are important for 
interaction (Greene et al., 1998; Genevaux et al., 2002), and especially positively 
charged residues in this region (Jiang et al., 2003). In human P58IPK, there is indeed a 
patch of positive charge on the surface of helix II (Figure 17B), but it is located on the 
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farther end from the HPD motif and is smaller than in most other J domain structures. 
Instead, there is a higher than usual proportion of hydrophobic residues immediately 
surrounding the HPD motif (Figure 17C).  
 
 
 
Figure 17. The J domain of P58IPK. (A) Cartoon representation of the J domain of P58IPK with the 
residues of the HPD motif shown as sticks. (B) Surface representation of the J domain, showing the 
electrostatic surface potential with positively charged residues in blue and negatively charged residues in 
red. Positively charged residues on helix II are labelled. (C) Surface representation of the J domain, with 
hydrophobic residues in green. Residues contributing to the hydrophobic patch adjacent to the HPD motif 
are labelled. 
 
 
The residues surrounding the HPD motif do not coincide with those that are the most 
conserved among the BiP-interacting ERdj proteins. In contrast, the residues in this 
region, as well as the entire J domain, exhibit a higher degree of conservation between 
different P58IPK homologues from various organisms. This could suggest differences in 
the interactions of the ERdj proteins with BiP, and give an insight into how the 
different family members are able to regulate the functions of BiP. Although the 
structure of J domains is generally well conserved, it is possible that properties such as 
the proportions of charged and hydrophobic surface could play a role in the regulation 
of which ERdj protein binds to BiP at a certain time point. Moreover, the significantly 
higher degree of J domain conservation among P58IPK homologues from different 
species would indicate that the properties of the J domain have a large impact on the 
functions or interactions of the protein. However, although the ERdj proteins all share 
the J domain, there is a high degree of variation between the additional domains, and 
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their functions and effects on BiP are also distinct. Therefore it is perhaps not unlikely 
that the additional domains in each ERdj protein influence the interaction and that the 
standard J domain-mediated binding of BiP is only part of the picture. In the case of 
P58IPK, this is very easy to imagine; it would be surprising if a large and elongated 
protein like this would interact with BiP only via the very tip of the protein. 
 
The exact binding sites for the other interaction partners of P58IPK are not known, and 
are difficult to predict based on the structure. The interaction with PKR has been 
mapped to TPR6 (Gale et al., 1996; Tang et al., 1996), but the exact residues involved 
remain to be determined. Analysis of the surface of TPR6 in human P58IPK does not 
show any obvious binding site. P52rIPK has been shown to bind to P58IPK at TPR7 (Gale 
et al., 2002). It has been suggested to bind via a charged domain, and the charged 
surface of TPR7 makes it plausible that this interaction is of an electrostatic nature. In 
the structure of the TPR domain of mouse P58IPK, a hydrophobic patch in the first 
subdomain was suggested to bind unfolded proteins. A patch at the same position and 
with the same shape is present also in human P58IPK, consistent with an important role 
for binding of unfolded proteins. 
 
 
In summary, we determined the structure of human P58IPK and analysed its surface with 
respect to potential binding sites for different interaction partners. The interaction site 
for BiP is particularly interesting, since it could provide some initial insights into how 
the different BiP-ERdj interactions could be regulated. The structure reveals that P58IPK 
is a flexible protein; most likely the conformation of the TPR domain can vary 
depending on what it is binding, and the linker between the TPR domain and the J 
domain certainly would allow adaptation of the relationship between the two domains. 
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3.5 Studies of the interaction between P58IPK and BiP (Paper V) 
Based on the structure of P58IPK, we could identify patches on the J domain of potential 
importance for interaction with BiP. The residues of these patches are not those that are 
most conserved among the ERdj proteins, and understanding how they are involved in 
interaction could explain how the ERdj proteins are able to regulate the different 
functions of BiP. In order to investigate these regions in more detail and to determine 
exactly which residues had a direct effect on BiP-binding, we created a series of 
mutants replacing residues in the surroundings of the HPD motif. Our aim was then to 
apply surface plasmon resonance (SPR) biosensor technology in order to quantify the 
interaction between native P58IPK and BiP, and compare the results to the interactions 
of each mutant. However, the interaction turned out to be far more complex than we 
had expected, and constructs we had not initially expected to interact with BiP in fact 
did. Due to the complexity of the SPR data, interpretation of our results was performed 
in collaboration with Professor Helena Danielson at the Department of Chemistry at 
Uppsala University, a specialist within the field of biomolecular interactions and the 
surface plasmon resonance technique. Instead of determining which parts of the J 
domain, in addition to the HPD motif, interacted with BiP, we analysed the interaction 
between the two proteins on a domain level, in order to try to better understand this 
complex interaction and to determine whether it includes not only the well-established J 
domain-component, but also the TPR domain.  
 
Since the interaction between P58IPK and BiP proved to be so complex, we also tried to 
employ other methods to help us understand it better. In particular, an enzyme assay 
measuring the ATPase activity of BiP in the presence of the P58IPK constructs used in 
the SPR measurements allowed us to determine whether the interactions we saw also 
had an effect on the ATPase activity. In order to fully understand the interaction 
between P58IPK and BiP, an ultimate aim would be to determine the structure of the 
complex of the two proteins. We have made attempts to crystallise the complex of 
P58IPK and BiP, but no crystals have been obtained, and co-crystallisation of Hsp70-
Hsp40 pairs is known to be notoriously difficult. In addition, we have tried to obtain a 
low-resolution structure of the complex using small-angle X-ray scattering (SAXS), but 
this was not successful.   
 
 
3.5.1 Surface plasmon resonance assays for studies of the P58IPK-BiP 
interaction 
In all SPR experiments, two different constructs of BiP were used as ligands; one 
construct spanning both the nucleotide-binding domain and the substrate-binding 
domain, and one comprising only the nucleotide-binding domain and the linker 
connecting the two domains. Different P58IPK constructs were used as analytes; the full-
length construct as used for solving the structure, and constructs of the separate TPR 
and J domains, as well as HPD-to-AAA mutated variants of the full-length and the J 
domain constructs. Based on previously published results, stating that the isolated TPR 
domain did not co-immunoprecipitate BiP, our intention was to employ this construct 
as a negative control.  
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We started out by measuring the interaction between the different constructs of native 
and HPD-mutated P58IPK and BiP. Interaction was clearly detected in all cases, but the 
sensorgrams were not well modelled by a simple 1:1 single-step interaction model, 
suggesting that the interactions were more complex. The shapes of the sensorgrams 
suggested that there could be several components to the interactions, and an induced-fit 
model gave reasonable curve fits, although not sufficient to explain the mode of 
interaction or to calculate the kinetic parameters. None of the alternative models 
explored gave better results or allowed us to determine the nature of the complexity, 
and we therefore performed a qualitative analysis of the sensorgrams (Figure 18).  
 
All tested constructs of P58IPK interacted with BiP, although the interactions differed 
qualitatively. The full-length construct and the isolated J domain both interacted, in 
agreement with previous results. More surprisingly, also the TPR domain of P58IPK 
interacted with both BiP constructs. However, the sensorgrams indicated that the 
interaction was of a different type than for constructs comprising the J domain. The 
interaction of the TPR domain with BiP was also different depending on whether full-
length BiP or the NBD alone was used. This suggested that there is an interaction 
between P58IPK and the SBD of BiP, and that the TPR domain, when connected to the J 
domain, could mediate this. Interactions outside the J domain have been suggested also 
for other ERdj-BiP pairs (Marcinowski et al., 2011), and it is plausible that the 
interaction with BiP is not mediated by the relatively small J domain alone, but that 
also the larger TPR domain binds to BiP. However, TPR motifs are known to mediate a 
wide range of protein-protein interactions, and it is possible that the TPR domain of 
P58IPK binds to BiP in a more unspecific way than the J domain. Based on our SPR data 
we cannot determine if this is the case, and although several of our normalised curves 
suggested a superstoichiometric interaction, equilibrium analysis showed that even 
these data are not consistent with a purely unspecific interaction. 
 
 
 
 
 
 
 
 
Figure 18. (Opposite page) Sensorgrams of P58IPK interacting with BiP. Full-length BiP (BiP_FL, 
residues 26-639) or the nucleotide-binding domain alone (BiP_NBD, residues 26-419) were immobilised 
on the chip. Five different constructs of P58IPK were used as analytes; full-length P58IPK (P58IPK_FL, 
residues 35-461), the J domain (P58IPK_J, residues 394-466), the TPR domain (P58IPK_TPR, residues 35-
401), the full-length protein with the HPD motif mutated (P58IPK_FL_HPD, residues 35-461, 
HPD422,423,424AAA), and the J domain with the HPD motif mutated (P58IPK_J_HPD, residues 394-
466, HPD422,423,424AAA). The raw data were double referenced and normalised with respect to the 
immobilisation levels and the different molecular weights of the immobilised protein and the analyte. (A) 
BiP_FL and P58IPK_FL. (B) BiP_FL and P58IPK_J. (C) BiP_FL and P58IPK_TPR. (D) BiP_FL and 
P58IPK_FL_HPD. (E) BiP_FL and P58IPK_J_HPD. (F) BiP_NBD and P58IPK_FL. (G) BiP_NBD and 
P58IPK_J. (H) BiP_NBD and P58IPK_TPR. (I) BiP_NBD and P58IPK_FL_HPD. (J) BiP_NBD and 
P58IPK_J_HPD. For panels A and F, for which the signal is weaker, a second copy of the sensorgrams 
with larger scale is added to the right of the original to facilitate interpretation. 
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3.5.2 Studies of P58IPK’s stimulation of BiP’s ATPase activity 
An important function of J domain proteins is to stimulate the ATPase activity of 
Hsp70 chaperones. With the aim of further investigating the functional interaction 
between P58IPK and BiP, and to support the interpretation of our SPR results, we 
measured the ATPase activity of BiP using a malachite green based colorimetric assay 
detecting the release of free phosphate. Figure 19 shows the results from measurements 
of the ATPase activity of BiP alone and in the presence of different constructs of 
P58IPK. Addition of full-length P58IPK led to an approximately eightfold stimulation of 
the ATPase activity of BiP. Also the isolated J domain increased the ATPase rate, but 
not to the same extent as the full-length protein. Interestingly, the full-length protein 
with a mutated HPD motif retained some capability to stimulate the ATPase activity, 
whereas the mutation in the J domain alone completely abolished the stimulation. No 
clear stimulating effect was observed upon addition of the TPR domain. 
 
 
 
 
Figure 19. ATPase activity of BiP. BiP was incubated alone or with different constructs of P58IPK. 
Reactions were started by addition of ATP, and the release of free phosphate was detected at the indicated 
time points by measurement of absorbance at 620 nm using a malachite green based colorimetric assay. 
The signal from ATP in buffer without proteins was subtracted to compensate for intrinsic hydrolysis. 
Error bars show standard deviation from three independent measurements. 
 
 
3.5.3 Functional interactions between P58IPK and BiP 
Combining the results from our SPR measurements and the ATPase activity assay, we 
see that the TPR domain of P58IPK is clearly involved in the BiP-stimulating effect, 
although only when attached to a J domain. On the other hand, the isolated TPR 
domain interacts with BiP, but the interaction seems to be different than that of the full-
length protein. Also between full-length P58IPK and the isolated J domain there is a 
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difference in interaction with BiP. These results all suggest that the interaction between 
the two proteins is dynamic, with the presence of one domain of P58IPK affecting the 
binding and function of the other, in particular the presence of the TPR domain 
enhancing the ATPase stimulating effect of the J domain, either by a second interaction 
or by allosteric effects.  
 
The HPD motif of P58IPK is clearly involved in the interaction with BiP, but it is 
certainly not the only site of interaction between the two large proteins; the TPR 
domain and the remainder of the J domain are also important for binding. The fact that 
the full-length mutated protein retains some capability to stimulate BiP’s ATPase 
activity confirms these results.  
 
 
In conclusion, we have studied the interaction of P58IPK with BiP and its ability to 
stimulate ATPase activity. Our finding that not only the conserved J domain, but also 
the TPR domain, interacts with BiP and participates in the stimulation of ATPase 
activity has taken us one step further on the way to understanding the role of P58IPK as 
a co-chaperone and how the different functions of BiP are regulated by the ERdj 
proteins. To fully understand the interaction between BiP and P58IPK would require 
detailed structural information on the complex between the two proteins, but attempts 
to achieve that using X-ray crystallography and SAXS have proven difficult. In order to 
expand the knowledge on this chaperone-co-chaperone pair, further interaction studies 
could instead be undertaken. For example, repeating the performed experiments using a 
non-hydrolysable ATP analogue might help to separate the initial binding from a 
subsequent conformational change. 
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4 CONCLUSIONS 
 
Within this thesis project, members of three complexes with different functions in the 
early secretory pathway have been studied. NMR spectroscopy and X-ray 
crystallography have been applied to determine the three-dimensional structures of 
MCFD2, Erv41p and P58IPK, and additional methods, such as CD spectroscopy and 
SPR biosensor technology, have been used to further characterise each protein.  
 
NMR studies of human MCFD2 resulted in the first structure of MCFD2 and 
demonstrated that the protein is unstructured in the absence of Ca2+ but adopts a 
predominantly ordered conformation upon binding of Ca2+. These findings gave an 
insight into the function of Ca2+ as an allosteric regulator of the interaction between 
MCFD2 and ERGIC-53. Characterisation of mutant variants of MCFD2 allowed us to 
explain the mechanisms by which they cause F5F8D, and also further emphasise the 
importance of the intact EF-hand motifs for the structural stability of MCFD2. 
 
X-ray crystallography was used to determine the first structure of Erv41p or any of its 
homologues. Detailed analysis of the surface properties of the protein enabled us to 
identify two potential binding sites for ligands or interaction partners. Although the 
structural homology between Erv41p and other proteins is limited, the β-sandwich 
structure in combination with the suggested role of Erv41p in glycoprotein processing 
is interesting, and provided a starting point for our further investigations to elucidate its 
function in the cell. Our results from thermal shift assays suggest that Ca2+ stabilises 
Erv41p. Considering the proposed role of Erv41p in glycoprotein processing or 
transport, this would not be surprising, since binding of Ca2+ is required for the function 
of other glycoprotein-interacting β-sandwich proteins in the secretory pathway, and this 
could be further investigated. Future studies of Erv41p should also include its complex 
partner Erv46p. We have made initial attempts to crystallise this protein alone, and 
although the structure of Erv46p would be interesting on its own, it is possible that we 
will only fully understand the roles of these proteins when we know how they interact, 
and a main goal would be to determine the three-dimensional structure of the complex 
between the two proteins.  
 
The structure of human P58IPK was determined by X-ray crystallography. Analysis of 
the surface of the J domain provided some initial insights into how interaction with BiP 
could be mediated, and how the functions of BiP could be regulated by the different 
members of the ERdj family. These findings led us to further investigate the interaction 
between P58IPK and BiP using SPR biosensor technology. The interaction between the 
two proteins turned out to be more complex than we initially expected, with both 
domains of P58IPK being involved in the interaction. These results were confirmed by 
measurements of the ability of different domains of P58IPK to stimulate the ATPase 
activity of BiP. We showed that, while the J domain alone is able to increase BiP’s 
ATPase activity, the presence of the TPR domain in the full-length protein significantly 
improves the stimulation. Although our findings are interesting, they do not provide the 
full story of the interaction between the two proteins. In order to find additional pieces 
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of the puzzle, many future experiments could be suggested, with the determination of 
the complex structure as a challenging ultimate aim. 
 
In conclusion, the structures determined within this thesis work have given new 
insights into different aspects of the early secretory pathway. Our studies of their 
interactions with complex partners or ligands have provided increased knowledge of 
their roles in the cell, and future studies will hopefully yield a full understanding of the 
functions of each protein and how these functions are facilitated by their interactions. 
 
 
 
 
 
 
  
  50
5 ACKNOWLEDGEMENTS 
Many people have contributed to making my years as a PhD student a great experience 
and now I would like to express my gratitude. 
 
First of all I would like to thank my main supervisor Jodie Guy for all the help during 
the years. Thank you for giving me freedom and support, for your patience and eye for 
detail. I think this has very much been a journey we made together.   
 
I would also like to thank Professors Ylva Lindqvist and Gunter Schneider for leading 
the group with an inspiring dedication to science, for sharing your experience and 
knowledge, and for creating a friendly atmosphere. Thank you Ylva for first accepting 
me as a PhD student and for your continued support as a co-supervisor throughout my 
time in the group. 
 
Jean-Marie Bourhis, my other co-supervisor, thank you for suggesting a challenge like 
P58IPK as a target for my studies, for the practical help during my first year in the lab, 
and for the long-distance encouragement during the remaining time. I have never 
forgotten about the dessert task. 
 
I would like to acknowledge the people we have collaborated with. Helena Danielson, 
thank you for convincing us about the usefulness of our Biacore data. Anne Tuukkanen, 
thank you for help with SAXS measurements and data analysis, and thank you for the 
guided tour in Hamburg. 
 
I also want to thank the students that have contributed to my project. So Yeon, thank 
you for your enthusiasm and for the interesting food choices. Isabel, without you I 
would never have tried to speak about chromatography in Spanish. Lance, you were so 
productive that I still have some of your samples left.  
 
Thanks to all the past and present members of the Molecular Structural Biology group:  
The PhD students who finished long before me, Catrine, Stina, Daniel and Hanna. To 
see you reach the goal inspired me to carry on with my project. The post-docs that left a 
long time ago, Laura, Mikko and Leif, and more recently, Jola, Agatha and Atsushi. A 
special thanks to my former office mates. Cyprian for your calm sense of humour and 
Jason for your ability to always cheer me up and our shared fascination with growing 
birches and oaks. Rajesh, thank you for showing me how to run the Biacore machine 
and for being an excellent host in Lisbon. Katja, for sharing the burden of the ER 
proteins and for the long lunches out. Edvard, thank you for introducing me to the lab 
work, for provision of bike tools, and for always being friendly and helpful, not least 
during my thesis writing. Magnus, thank you for your good mood, for being such a 
sensible person, and for shared teaching experiences. Katharina, I am so happy that you 
joined the group. Thank you for listening to me when I needed it the most, and for 
letting me listen to you. And thanks for the company on trips in all weathers. Dominik, 
thanks for thoughtful discussions about life and science and for good advice concerning 
insect cells. Sorry for hiding my proteins in the freezer, soon you can inherit them all. 
Ming Wei, for interesting discussions about weight lifting and nutrition. I hope you will 
  51
soon be back in the gym again. Dominic, I wish we had got the opportunity to sing and 
play in the same concert. Eva Maria, good luck with the skiing, I would be really 
tempted to go for another Vasalopp. Ömer, thanks for new perspectives on Sweden and 
the Swedes, for your imaginative associations, and for teaching me the importance of 
salad dressing. Robert, for your long and fascinating stories and for the way you always 
seem happy to share your knowledge. Bernie, for always being ready to give helpful 
scientific advice and for not hesitating to take the Swedish last piece of cake. Doreen, 
thanks for quietly reorganising the seminar list when I baked semlor instead of 
preparing my talk.  
 
Thanks Victoria for your quick responses to all practical questions, and thank you Eva 
for your help and care during my early years in the group. Ahmad, thank you for 
running the lab and for company at coffee time. 
 
I would also like to thank the teaching unit at MBB: Åke Rökaeus, Susanne Rothstein, 
Susie Björkholm, Agneta Nordberg and Christine Jansson. You have helped making 
teaching fun and interesting, and I think that I have often learnt just as much as the 
students. And all the other people I have met at MBB, thanks for practical help and nice 
company. 
 
Tack till alla vänner utanför arbetet. Tack för att ni har lyssnat på mina historier om 
vedermödorna i labbet, och för att ni har fått mig att tänka på helt andra saker.  
 
Slutligen vill jag tacka min familj. Tack Henrik för squashmatcher, våffelluncher och 
diskussioner om doktorandlivet. Tack Lovisa för strapatser i kajak och på skidor. 
Mamma och Pappa, tack för er omtanke, er hjälpsamhet och ert oändliga stöd i allt jag 
tar mig för. Ni betyder så mycket. 
 
 
  52
6 REFERENCES 
 
Abdallah, H.E., Gouider, E., Amor, M.B., Jlizi, A., Meddeb, B., Elgaaied, A., 2010. 
Molecular analysis in two Tunisian families with combined factor V and factor 
VIII deficiency. Haemophilia 16, 801-804. 
 
Adachi, Y., Yamamoto, K., Okada, T., Yoshida, H., Harada, A., Mori, K., 2008. ATF6 
Is a Transcription Factor Specializing in the Regulation of Quality Control 
Proteins in the Endoplasmic Reticulum. Cell Structure and Function 33, 75-89. 
 
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., Walter, P., 2002. Molecular 
Biology of the Cell, 4th ed. Garland Science, New York. 
 
Antonin, W., Meyer, H.A., Hartmann, E., 2000. Interactions between Spc2p and other 
components of the endoplasmic reticulum translocation sites of the yeast 
Saccharomyces cerevisiae. Journal of Biological Chemistry 275, 34068-34072. 
 
Appenzeller, C., Andersson, H., Kappeler, F., Hauri, H.P., 1999. The lectin ERGIC-53 
is a cargo transport receptor for glycoproteins. Nature Cell Biology 1, 330-334. 
 
Appenzeller-Herzog, C., Hauri, H.P., 2006. The ER-Golgi intermediate compartment 
(ERGIC): in search of its identity and function. Journal of Cell Science 119, 
2173-2183. 
 
Appenzeller-Herzog, C., Nyfeler, B., Burkhard, P., Santamaria, I., Lopez-Otin, C., 
Hauri, H.P., 2005. Carbohydrate- and conformation-dependent cargo capture 
for ER-exit. Molecular Biology of the Cell 16, 1258-1267. 
 
Ashby, M.C., Tepikin, A.V., 2001. ER calcium and the functions of intracellular 
organelles. Seminars in Cell & Developmental Biology 12, 11-17. 
 
Awad, W., Estrada, I., Shen, Y., Hendershot, L.M., 2008. BiP mutants that are unable 
to interact with endoplasmic reticulum DnaJ proteins provide insights into 
interdomain interactions in BiP. Proceedings of the National Academy of 
Sciences of the United States of America 105, 1164-1169. 
 
Barber, G.N., Thompson, S., Lee, T.G., Strom, T., Jagus, R., Darveau, A., Katze, M.G., 
1994. The 58-kilodalton inhibitor of the interferon-induced double-stranded 
RNA-activated protein-kinase is a tetratricopeptide repeat protein with 
oncogenic properties. Proceedings of the National Academy of Sciences of the 
United States of America 91, 4278-4282. 
 
Barlowe, C., 2003. Signals for COPII-dependent export from the ER: what's the ticket 
out? Trends in Cell Biology 13, 295-300. 
 
Barlowe, C., Schekman, R., 1993. Sec12 encodes a guanine-nucleotide-exchange factor 
essential for transport vesicle budding from the ER. Nature 365, 347-349. 
 
  53
Barlowe, C., Orci, L., Yeung, T., Hosobuchi, M., Hamamoto, S., Salama, N., Rexach, 
M.F., Ravazzola, M., Amherdt, M., Schekman, R., 1994. COPII - a membrane 
coat formed by Sec proteins that drive vesicle budding from the endoplasmic-
reticulum. Cell 77, 895-907. 
 
Barlowe, C.K., Miller, E.A., 2013. Secretory Protein Biogenesis and Traffic in the 
Early Secretory Pathway. Genetics 193, 383-410. 
 
Bertolotti, A., Zhang, Y.H., Hendershot, L.M., Harding, H.P., Ron, D., 2000. Dynamic 
interaction of BiP and ER stress transducers in the unfolded-protein response. 
Nature Cell Biology 2, 326-332. 
 
Blatch, G.L., Lassle, M., 1999. The tetratricopeptide repeat: a structural motif 
mediating protein-protein interactions. Bioessays 21, 932-939. 
 
Blobel, G., Dobberstein, B., 1975. Transfer of proteins across membranes  I. Presence 
of proteolytically processed and unprocessed nascent immunoglobulin light-
chains on membrane-bound ribosomes of murine myeloma. Journal of Cell 
Biology 67, 835-851. 
 
Breuza, L., Halbeisen, R., Jeno, P., Otte, S., Barlowe, C., Hong, W.J., Hauri, H.P., 
2004. Proteomics of endoplasmic reticulum-golgi intermediate compartment 
(ERGIC) membranes from brefeldin A-treated HepG2 cells identifies ERGIC-
32, a new cycling protein that interacts with human Erv46. Journal of 
Biological Chemistry 279, 47242-47253. 
 
Brocker, C., Engelbrecht-Vandre, S., Ungermann, C., 2010. Multisubunit Tethering 
Complexes and Their Role in Membrane Fusion. Current Biology 20, R943-
R952. 
 
Brodsky, J.L., 2012. Cleaning Up: ER-Associated Degradation to the Rescue. Cell 151, 
1163-1167. 
 
Budnik, A., Stephens, D.J., 2009. ER exit sites - Localization and control of COPII 
vesicle formation. Febs Letters 583, 3796-3803. 
 
Bulleid, N.J., Ellgaard, L., 2011. Multiple ways to make disulfides. Trends in 
Biochemical Sciences 36, 485-492. 
 
Cai, H.Q., Reinisch, K., Ferro-Novick, S., 2007. Coats, tethers, Rabs, and SNAREs 
work together to mediate the intracellular destination of a transport vesicle. 
Developmental Cell 12, 671-682. 
 
Cao, S.S., Kaufman, R.J., 2012. Unfolded protein response. Current Biology 22, R622-
R626. 
 
Carrara, M., Prischi, F., Ali, M.M.U., 2013. UPR Signal Activation by Luminal Sensor 
Domains. International Journal of Molecular Sciences 14, 6454-6466. 
 
Cheetham, M.E., Caplan, A.J., 1998. Structure, function and evolution of DnaJ: 
conservation and adaptation of chaperone function. Cell Stress & Chaperones 3, 
28-36. 
  54
Cox, J.S., Walter, P., 1996. A novel mechanism for regulating activity of a transcription 
factor that controls the unfolded protein response. Cell 87, 391-404. 
 
Csala, M., Margittai, E., Banhegyi, G., 2010. Redox Control of Endoplasmic Reticulum 
Function. Antioxidants & Redox Signaling 13, 77-108. 
 
Cunnea, P.M., Miranda-Vizuete, A., Bertoli, G., Simmen, T., Damdimopoulos, A.E., 
Hermann, S., Leinonen, S., Huikko, M.P., Gustafsson, J.A., Sitia, R., Spyrou, 
G., 2003. ERdJ5, an endoplasmic reticulum (ER)-resident protein containing 
DnaJ and thioredoxin domains, is expressed in secretory cells or following ER 
stress. Journal of Biological Chemistry 278, 1059-1066. 
 
Cunningham, M.A., Pipe, S.W., Zhang, B., Hauri, H.P., Ginsburg, D., Kaufman, R.J., 
2003. LMAN1 is a molecular chaperone for the secretion of coagulation factor 
VIII. Journal of Thrombosis and Haemostasis 1, 2360-2367. 
 
Cyr, D.M., Lu, X.Y., Douglas, M.G., 1992. Regulation of Hsp70 Function by a 
Eukaryotic DnaJ Homolog. Journal of Biological Chemistry 267, 20927-20931. 
 
Cyr, D.M., Langer, T., Douglas, M.G., 1994. DnaJ-like proteins: molecular chaperones 
and specific regulators of Hsp70. Trends in Biochemical Sciences 19, 176-181. 
 
Dancourt, J., Barlowe, C., 2010. Protein Sorting Receptors in the Early Secretory 
Pathway. Annual Review of Biochemistry 79, 777-802. 
 
Dong, C.M., Nichols, C.D., Guo, J.H., Huang, W., Lambert, N.A., Wu, G.Y., 2012. A 
Triple Arg Motif Mediates a2B-Adrenergic Receptor Interaction with 
Sec24C/D and Export. Traffic 13, 857-868. 
 
Dong, M., Bridges, J.P., Apsley, K., Xu, Y., Weaver, T.E., 2008. ERdj4 and ERdj5 are 
required for endoplasmic reticulum-associated protein degradation of misfolded 
surfactant protein C. Molecular Biology of the Cell 19, 2620-2630. 
 
Dudek, J., Greiner, M., Muller, A., Hendershot, L.M., Kopsch, K., Nastainczyk, W., 
Zimmermann, R., 2005. ERj1p has a basic role in protein biogenesis at the 
endoplasmic reticulum. Nature Structural & Molecular Biology 12, 1008-1014. 
 
Ellgaard, L., Helenius, A., 2003. Quality control in the endoplasmic reticulum. Nature 
Reviews Molecular Cell Biology 4, 181-191. 
 
Elmahmoudi, H., Wigren, E., Laatiri, A., Jlizi, A., Elgaaied, A., Gouider, E., Lindqvist, 
Y., 2011. Analysis of newly detected mutations in the MCFD2 gene giving rise 
to combined deficiency of coagulation factors V and VIII. Haemophilia 17, 
E923-E927. 
 
Farquhar, M.G., Palade, G.E., 1998. The Golgi apparatus: 100 years of progress and 
controversy. Trends in Cell Biology 8, 2-10. 
 
Gale, M., Tan, S.L., Wambach, M., Katze, M.G., 1996. Interaction of the interferon-
induced PKR protein kinase with inhibitory proteins p58(IPK) and vaccinia 
virus K3L is mediated by unique domains: Implications for kinase regulation. 
Molecular and Cellular Biology 16, 4172-4181. 
  55
Gale, M., Blakely, C.M., Darveau, A., Romano, P.R., Korth, M.J., Katze, M.G., 2002. 
P52(rIPK) regulates the molecular cochaperone P58(IPK) to mediate control of 
the RNA-dependent protein kinase in response to cytoplasmic stress. 
Biochemistry 41, 11878-11887. 
 
Gale, M., Blakely, C.M., Hopkins, D.A., Melville, M.W., Wambach, M., Romano, 
P.R., Katze, M.G., 1998. Regulation of interferon-induced protein kinase PKR: 
Modulation of p58(IPK) inhibitory function by a novel protein, P52(rIPK). 
Molecular and Cellular Biology 18, 859-871. 
 
Gardner, B.M., Pincus, D., Gotthardt, K., Gallagher, C.M., Walter, P., 2013. 
Endoplasmic Reticulum Stress Sensing in the Unfolded Protein Response. Cold 
Spring Harbor Perspectives in Biology 5, 15. 
 
Gauss, R., Kanehara, K., Carvalho, P., Ng, D.T.W., Aebi, M., 2011. A Complex of 
Pdi1p and the Mannosidase Htm1p Initiates Clearance of Unfolded 
Glycoproteins from the Endoplasmic Reticulum. Molecular Cell 42, 782-793. 
 
Genevaux, P., Schwager, F., Georgopoulos, C., Kelley, W.L., 2002. Scanning 
mutagenesis identifies amino acid residues essential for the in vivo activity of 
the Escherichia coli DnaJ (Hsp40) J-domain. Genetics 162, 1045-1053. 
 
Gething, M.J., 1999. Role and regulation of the ER chaperone BiP. Seminars in Cell & 
Developmental Biology 10, 465-472. 
 
Gething, M.J., McCammon, K., Sambrook, J., 1986. Expression of wild-type and 
mutant forms of influenza hemagglutinin - the role of folding in intracellular-
transport. Cell 46, 939-950. 
 
Gifford, J.L., Walsh, M.P., Vogel, H.J., 2007. Structures and metal-ion-binding 
properties of the Ca2+-binding helix-loop-helix EF-hand motifs. Biochemical 
Journal 405, 199-221. 
 
Gilchrist, A., Au, C.E., Hiding, J., Bell, A.W., Fernandez-Rodriguez, J., Lesimple, S., 
Nagaya, H., Roy, L., Gosline, S.J.C., Hallett, M., Paiement, J., Kearney, R.E., 
Nilsson, T., Bergeron, J.J.M., 2006. Quantitative proteomics analysis of the 
secretory pathway. Cell 127, 1265-1281. 
 
Greene, M.K., Maskos, K., Landry, S.J., 1998. Role of the J-domain in the cooperation 
of Hsp40 with Hsp70. Proceedings of the National Academy of Sciences of the 
United States of America 95, 6108-6113. 
 
Gulow, K., Bienert, D., Haas, I.G., 2002. BiP is feed-back regulated by control of 
protein translation efficiency. Journal of Cell Science 115, 2443-2452. 
 
Haas, I.G., Wabl, M., 1983. Immunoglobulin heavy-chain binding-protein. Nature 306, 
387-389. 
 
Hamman, B.D., Hendershot, L.M., Johnson, A.E., 1998. BiP maintains the 
permeability barrier of the ER membrane by sealing the lumenal end of the 
translocon pore before and early in translocation. Cell 92, 747-758. 
 
  56
Hanisch, F.A., 2001. O-glycosylation of the mucin type. Biological Chemistry 382, 
143-149. 
 
Harding, H.P., Zhang, Y.H., Ron, D., 1999. Protein translation and folding are coupled 
by an endoplasmic-reticulum-resident kinase. Nature 397, 271-274. 
 
Harding, H.P., Novoa, I., Zhang, Y.H., Zeng, H.Q., Wek, R., Schapira, M., Ron, D., 
2000. Regulated translation initiation controls stress-induced gene expression in 
mammalian cells. Molecular Cell 6, 1099-1108. 
 
Harty, C., Strahl, S., Romisch, K., 2001. O-mannosylation protects mutant alpha-factor 
precursor from endoplasmic reticulum-associated degradation. Molecular 
Biology of the Cell 12, 1093-1101. 
 
Hauri, H.P., Kappeler, F., Andersson, H., Appenzeller, C., 2000. ERGIC-53 and traffic 
in the secretory pathway. Journal of Cell Science 113, 587-596. 
 
Haze, K., Yoshida, H., Yanagi, H., Yura, T., Mori, K., 1999. Mammalian transcription 
factor ATF6 is synthesized as a transmembrane protein and activated by 
proteolysis in response to endoplasmic reticulum stress. Molecular Biology of 
the Cell 10, 3787-3799. 
 
Helenius, A., Aebi, M., 2004. Roles of N-linked glycans in the endoplasmic reticulum. 
Annual Review of Biochemistry 73, 1019-1049. 
 
Hirayama, H., Fujita, M., Yoko-O, T., Jigami, Y., 2008. O-mannosylation is required 
for degradation of the endoplasmic reticulum-associated degradation substrate 
Gas1*p via the ubiquitin/proteasome pathway in Saccharomyces cerevisiae. 
Journal of Biochemistry 143, 555-567. 
 
Hohfeld, J., Jentsch, S., 1997. GrpE-like regulation of the Hsc70 chaperone by the anti-
apoptotic protein BAG-1. EMBO Journal 16, 6209-6216. 
 
Hollien, J., Weissman, J.S., 2006. Decay of endoplasmic reticulum-localized mRNAs 
during the unfolded protein response. Science 313, 104-107. 
 
Holm, L., Rosenström, P., 2010. Dali server: conservation mapping in 3D. Nucleic 
Acids Research 38, W545-W549. 
 
Hosoda, A., Kimata, Y., Tsuru, A., Kohno, K., 2003. JPDI, a novel endoplasmic 
reticulum-resident protein containing both a BiP-interacting J-domain and 
thioredoxin-like motifs. Journal of Biological Chemistry 278, 2669-2676. 
 
Itin, C., Roche, A.C., Monsigny, M., Hauri, H.P., 1996. ERGIC-53 is a functional 
mannose-selective and calcium-dependent human homologue of leguminous 
lectins. Molecular Biology of the Cell 7, 483-493. 
 
Ivaskevicius, V., Windyga, J., Baran, B., Bykowska, K., Daugela, L., Watzka, M., 
Seifried, E., Olenburg, J., 2008. The first case of combined coagulation factor V 
and coagulation factor VIII deficiency in Poland due to a novel p.Tyr135Asn 
missense mutation in the MCFD2 gene. Blood Coagulation & Fibrinolysis 19, 
531-534. 
  57
Jackson, M.R., Nilsson, T., Peterson, P.A., 1990. Identification of a consensus motif for 
retention of transmembrane proteins in the endoplasmic-reticulum. EMBO 
Journal 9, 3153-3162. 
 
Jayandharan, G., Spreafico, M., Viswabandya, A., Chandy, M., Srivastava, A., 
Peyvandi, F., 2007. Mutations in the MCFD2 gene are predominant among 
patients with hereditary combined FV and FVIII deficiency (F5F8D) in India. 
Haemophilia 13, 413-419. 
 
Jiang, J., Taylor, A.B., Prasad, K., Ishikawa-Brush, Y., Hart, P.J., Lafer, E.M., Sousa, 
R., 2003. Structure-function analysis of the auxilin J-domain reveals an 
extended Hsc70 interaction interface. Biochemistry 42, 5748-5753. 
 
Kampinga, H.H., Craig, E.A., 2010. The HSP70 chaperone machinery: J proteins as 
drivers of functional specificity. Nature Reviews Molecular Cell Biology 11, 
579-592. 
 
Kappeler, F., Klopfenstein, D.R.C., Foguet, M., Paccaud, J.P., Hauri, H.P., 1997. The 
recycling of ERGIC-53 in the early secretory pathway - ERGIC-53 carries a 
cytosolic endoplasmic reticulum exit determinant interacting with COPII. 
Journal of Biological Chemistry 272, 31801-31808. 
 
Kawasaki, N., Ichikawa, Y., Matsuo, I., Totani, K., Matsumoto, N., Ito, Y., Yamamoto, 
K., 2008. The sugar-binding ability of ERGIC-53 is enhanced by its interaction 
with MCFD2. Blood 111, 1972-1979. 
 
Kelleher, D.J., Gilmore, R., 2006. An evolving view of the eukaryotic 
oligosaccharyltransferase. Glycobiology 16, 47R-62R. 
 
Kimata, Y., Kimata, Y.L., Shimizu, Y., Abe, H., Farcasanu, R.C., Takeuchi, M., Rose, 
M.D., Kohno, K., 2003. Genetic evidence for a role of BiP/Kar2 that regulates 
Ire1 in response to accumulation of unfolded proteins. Molecular Biology of the 
Cell 14, 2559-2569. 
 
Kimura, T., Hosoda, Y., Sato, Y., Kitamura, Y., Ikeda, T., Horibe, T., Kikuchi, M., 
2005. Interactions among yeast protein-disulfide isomerase proteins and 
endoplasmic reticulum chaperone proteins influence their activities. Journal of 
Biological Chemistry 280, 31438-31441. 
 
Kornfeld, R., Kornfeld, S., 1985. Assembly of asparagine-linked oligosaccharides. 
Annual Review of Biochemistry 54, 631-664. 
 
Kozutsumi, Y., Segal, M., Normington, K., Gething, M.J., Sambrook, J., 1988. The 
presence of malfolded proteins in the endoplasmic-reticulum signals the 
induction of glucose-regulated proteins. Nature 332, 462-464. 
 
Kreis, T.E., Lodish, H.F., 1986. Oligomerization is essential for transport of vesicular 
stomatitis viral glycoprotein to the cell-surface. Cell 46, 929-937. 
 
Kretsinger, R.H., 1976. Calcium-binding proteins. Annual Review of Biochemistry 45, 
239-266. 
 
  58
Krissinel, E., Henrick, K., 2004. Secondary-structure matching (SSM), a new tool for 
fast protein structure alignment in three dimensions. Acta Crystallographica 
Section D - Biological Crystallography 60, 2256-2268. 
 
Ladiges, W.C., Knoblaugh, S.E., Morton, J.F., Korth, M.J., Sopher, B.L., Baskin, C.R., 
MacAuley, A., Goodman, A.G., LeBoeuf, R.C., Katze, M.G., 2005. Pancreatic 
beta-cell failure and diabetes in mice with a deletion mutation of the 
endoplasmic reticulum molecular chaperone gene P58(IPK). Diabetes 54, 1074-
1081. 
 
Lahtinen, U., Svensson, K., Pettersson, R.F., 1999. Mapping of structural determinants 
for the oligomerization of p58, a lectin-like protein of the intermediate 
compartment and cis-Golgi. European Journal of Biochemistry 260, 392-397. 
 
Lee, M.C.S., Miller, E.A., 2007. Molecular mechanisms of COPII vesicle formation. 
Seminars in Cell & Developmental Biology 18, 424-434. 
 
Lee, M.C.S., Orci, L., Hamamoto, S., Futai, E., Ravazzola, M., Schekman, R., 2005. 
Sar1p N-terminal helix initiates membrane curvature and completes the fission 
of a COPII vesicle. Cell 122, 605-617. 
 
Lee, T.G., Tomita, J., Hovanessian, A.G., Katze, M.G., 1990. Purification and partial 
characterization of a cellular inhibitor of the interferon-induced protein kinase 
of Mr 68,000 from influenza virus-infected cells. Proceedings of the National 
Academy of Sciences of the United States of America 87, 6208-6212. 
 
Lee, Y.K., Brewer, J.W., Hellman, R., Hendershot, L.M., 1999. BiP and 
immunoglobulin light chain cooperate to control the folding of heavy chain and 
ensure the fidelity of immunoglobulin assembly. Molecular Biology of the Cell 
10, 2209-2219. 
 
Lewis, M.J., Pelham, H.R.B., 1990. A human homolog of the yeast HDEL receptor. 
Nature 348, 162-163. 
 
Lewis, M.J., Sweet, D.J., Pelham, H.R.B., 1990. The ERD2 Gene Determines the 
Specificity of the Luminal ER Protein Retention System. Cell 61, 1359-1363. 
 
Lewit-Bentley, A., Rety, S., 2000. EF-hand calcium-binding proteins. Current Opinion 
in Structural Biology 10, 637-643. 
 
Liberek, K., Marszalek, J., Ang, D., Georgopoulos, C., Zylicz, M., 1991. Escherichia 
coli DnaJ and GrpE heat shock proteins jointly stimulate ATPase activity of 
DnaK. Proceedings of the National Academy of Sciences of the United States 
of America 88, 2874-2878. 
 
Ma, D.K., Zerangue, N., Lin, Y.F., Collins, A., Yu, M., Jan, Y.N., Jan, L.Y., 2001. 
Role of ER export signals in controlling surface potassium channel numbers. 
Science 291, 316-319. 
 
 
 
  59
Ma, K., Vattem, K.M., Wek, R.C., 2002. Dimerization and release of molecular 
chaperone inhibition facilitate activation of eukaryotic initiation factor-2 kinase 
in response to endoplasmic reticulum stress. Journal of Biological Chemistry 
277, 18728-18735. 
 
Malkus, P., Jiang, F., Schekman, R., 2002. Concentrative sorting of secretory cargo 
proteins into COPII-coated vesicles. Journal of Cell Biology 159, 915-921. 
 
Marcinowski, M., Holler, M., Feige, M.J., Baerend, D., Lamb, D.C., Buchner, J., 2011. 
Substrate discrimination of the chaperone BiP by autonomous and 
cochaperone-regulated conformational transitions. Nature Structural & 
Molecular Biology 18, 150-158. 
 
Mayer, M.P., 2013. Hsp70 chaperone dynamics and molecular mechanism. Trends in 
Biochemical Sciences 38, 507-514. 
 
Mayer, M.P., Bukau, B., 2005. Hsp70 chaperones: Cellular functions and molecular 
mechanism. Cellular and Molecular Life Sciences 62, 670-684. 
 
Mazzarello, P., Calligaro, A., Vannini, V., Muscatello, U., 2003. Timeline - The 
sarcoplasmic reticulum: its discovery and rediscovery. Nature Reviews 
Molecular Cell Biology 4, 69-74. 
 
Meimaridou, E., Gooljar, S.B., Chapple, J.P., 2009. From hatching to dispatching: the 
multiple cellular roles of the Hsp70 molecular chaperone machinery. Journal of 
Molecular Endocrinology 42, 1-9. 
 
Mellman, I., Simons, K., 1992. The Golgi Complex: In Vitro Veritas? Cell 68, 829-
840. 
 
Meyer, H.A., Grau, H., Kraft, R., Kostka, S., Prehn, S., Kalies, K.U., Hartmann, E., 
2000. Mammalian Sec61 is associated with Sec62 and Sec63. Journal of 
Biological Chemistry 275, 14550-14557. 
 
Miller, E., Antonny, B., Hamamoto, S., Schekman, R., 2002. Cargo selection into 
COPII vesicles is driven by the Sec24p subunit. EMBO Journal 21, 6105-6113. 
 
Morais, V.A., Brito, C., Pijak, D.S., Crystal, A.S., Fortna, R.R., Li, T., Wong, P.C., 
Doms, R.W., Costa, J., 2006. N-glycosylation of human nicastrin is required for 
interaction with the lectins from the secretory pathway calnexin and ERGIC-53. 
Biochimica Et Biophysica Acta-Molecular Basis of Disease 1762, 802-810. 
 
Mori, K., 2009. Signalling Pathways in the Unfolded Protein Response: Development 
from Yeast to Mammals. Journal of Biochemistry 146, 743-750. 
 
Munro, S., Pelham, H.R.B., 1986. An Hsp70-like Protein in the ER: Identity with the 
78 kd Glucose-Regulated Protein and Immunoglobulin Heavy Chain Binding 
Protein. Cell 46, 291-300. 
 
Nakamura, N., Wei, J.H., Seemann, J., 2012. Modular organization of the mammalian 
Golgi apparatus. Current Opinion in Cell Biology 24, 467-474. 
 
  60
Neve, E.P.A., Lahtinen, U., Pettersson, R.F., 2005. Oligomerization and interacellular 
localization of the glycoprotein receptor ERGIC-53 is independent of disulfide 
bonds. Journal of Molecular Biology 354, 556-568. 
 
Nichols, W.C., Seligsohn, U., Zivelin, A., Terry, V.H., Hertel, C.E., Wheatley, M.A., 
Moussalli, M.J., Hauri, H.P., Ciavarella, N., Kaufman, R.J., Ginsburg, D., 1998. 
Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause 
combined deficiency of coagulation factors V and VIII. Cell 93, 61-70. 
 
Nilsson, T., Pypaert, M., Hoe, M.H., Slusarewicz, P., Berger, E.G., Warren, G., 1993. 
Overlapping Distribution of Two Glycosyltransferases in the Golgi Apparatus 
of HeLa Cells. Journal of Cell Biology 120, 5-13. 
 
Nishikawa, S., Fewell, S.W., Kato, Y., Brodsky, J.L., Endo, T., 2001. Molecular 
chaperones in the yeast endoplasmic reticulum maintain the solubility of 
proteins for retrotranslocation and degradation. Journal of Cell Biology 153, 
1061-1069. 
 
Nishimura, N., Balch, W.E., 1997. A di-acidic signal required for selective export from 
the endoplasmic reticulum. Science 277, 556-558. 
 
Nufer, O., Kappeler, F., Guldbrandsen, S., Hauri, H.P., 2003. ER export of ERGIC-53 
is controlled by cooperation of targeting determinants in all three of its 
domains. Journal of Cell Science 116, 4429-4440. 
 
Nyfeler, B., Zhang, B., Ginsburg, D., Kaufman, R.J., Hauri, H.P., 2006. Cargo 
selectivity of the ERGIC-53/MCFD2 transport receptor complex. Traffic 7, 
1473-1481. 
 
Oeri, J., Matter, M., Isenschmid, H., Hauser, F., Koller, F. 1954. Congenital factor V 
deficiency (parahemophilia) with true hemophilia in two brothers, pp. 575-588, 
Vol. 58, Bibliotheca Paediatrica. 
 
Oka, O.B.V., Pringle, M.A., Schopp, I.M., Braakman, I., Bulleid, N.J., 2013. ERdj5 Is 
the ER Reductase that Catalyzes the Removal of Non-Native Disulfides and 
Correct Folding of the LDL Receptor. Molecular Cell 50, 793-804. 
 
Okamura, K., Kimata, Y., Higashio, H., Tsuru, A., Kohno, K., 2000. Dissociation of 
Kar2p/BiP from an ER sensory molecule, Ire1p, triggers the unfolded protein 
response in yeast. Biochemical and Biophysical Research Communications 279, 
445-450. 
 
Orci, L., Ravazzola, M., Mack, G.J., Barlowe, C., Otte, S., 2003. Mammalian Erv46 
localizes to the endoplasmic reticulum-Golgi intermediate compartment and to 
cis-Golgi cisternae. Proceedings of the National Academy of Sciences of the 
United States of America 100, 4586-4591. 
 
Otero, J.H., Lizák, B., Hendershot, L.M., 2010. Life and death of a BiP substrate. 
Seminars in Cell & Developmental Biology 21, 472-478. 
 
 
  61
Otsu, W., Kurooka, T., Otsuka, Y., Sato, K., Inaba, M., 2013. A New Class of 
Endoplasmic Reticulum Export Signal Phi X Phi X Phi for Transmembrane 
Proteins and Its Selective Interaction with Sec24C. Journal of Biological 
Chemistry 288, 18521-18532. 
 
Otte, S., Barlowe, C., 2002. The Erv41p-Erv46p complex: multiple export signals are 
required in trans for COPII-dependent transport from the ER. EMBO Journal 
21, 6095-6104. 
 
Otte, S., Belden, W.J., Heidtman, M., Liu, J., Jensen, O.N., Barlowe, C., 2001. Erv41p 
and Erv46p: New components of COPII vesicles involved in transport between 
the ER and Golgi complex. Journal of Cell Biology 152, 503-517. 
 
Paetzel, M., Karla, A., Strynadka, N.C.J., Dalbey, R.E., 2002. Signal peptidases. 
Chemical Reviews 102, 4549-4579. 
 
Palade, G.E., 1956. The endoplasmic reticulum. Journal of Biophysical and 
Biochemical Cytology 2, 85-98. 
 
Paroutis, P., Touret, N., Grinstein, S., 2004. The pH of the secretory pathway: 
Measurement, determinants, and regulation. Physiology 19, 207-215. 
 
Petrova, K., Oyadomari, S., Hendershot, L.M., Ron, D., 2008. Regulated association of 
misfolded endoplasmic reticulum lumenal proteins with P58/DNAJc3. EMBO 
Journal 27, 2862-2872. 
 
Pezzati, R., Bossi, M., Podini, P., Meldolesi, J., Grohovaz, F., 1997. High-resolution 
calcium mapping of the endoplasmic reticulum Golgi exocytic membrane 
system - Electron energy loss imaging analysis of quick frozen freeze dried 
PC12 cells. Molecular Biology of the Cell 8, 1501-1512. 
 
Pfeffer, S.R., Rothman, J.E., 1987. Biosynthetic protein transport and sorting by the 
endoplasmic reticulum and Golgi. Annual Review of Biochemistry 56, 829-
852. 
 
Porter, K.R., Thompson, H.P., 1948. A particulate body associated with epithelial cells 
cultured from mammary carcinomas of mice of a milk-factor strain. Journal of 
Experimental Medicine 88, 15-24. 
 
Porter, K.R., Claude, A., Fullam, E.F., 1945. A study of tissue culture cells by electron 
microscopy - methods and preliminary observations. Journal of Experimental 
Medicine 81, 233-246. 
 
Prins, D., Michalak, M., 2011. Organellar Calcium Buffers. Cold Spring Harbor 
Perspectives in Biology 3, a004069. 
 
Qin, S., Zhou, H.X., 2007. meta-PPISP: a meta web server for protein-protein 
interaction site prediction. Bioinformatics 23, 3386-3387. 
 
Raykhel, I., Alanen, H., Salo, K., Jurvansuu, J., Nguyen, V.D., Latva-Ranta, M., 
Ruddock, L., 2007. A molecular specificity code for the three mammalian 
KDEL receptors. Journal of Cell Biology 179, 1193-1204. 
  62
Ritossa, F., 1962. New Puffing Pattern Induced by Temperature Shock and DNP in 
Drosophila. Experientia 18, 571-573. 
 
Ritossa, F., 1996. Discovery of the heat shock response. Cell Stress & Chaperones 1, 
97-98. 
 
Rudiger, S., Germeroth, L., SchneiderMergener, J., Bukau, B., 1997. Substrate 
specificity of the DnaK chaperone determined by screening cellulose-bound 
peptide libraries. EMBO Journal 16, 1501-1507. 
 
Rutkowski, D.T., Kang, S.W., Goodman, A.G., Garrison, J.L., Taunton, J., Katze, 
M.G., Kaufman, R.J., Hegde, R.S., 2007. The role of p58IPK in protecting the 
stressed endoplasmic reticulum. Molecular Biology of the Cell 18, 3681-3691. 
 
Sato, K., Nakano, A., 2002. Emp47p and its close homolog Emp46p have a tyrosine-
containing endoplasmic reticulum exit signal and function in glycoprotein 
secretion in Saccharomyces cerevisiae. Molecular Biology of the Cell 13, 2518-
2532. 
 
Sato, K., Sato, M., Nakano, A., 1997. Rer1p as common machinery for the 
endoplasmic reticulum localization of membrane proteins. Proceedings of the 
National Academy of Sciences of the United States of America 94, 9693-9698. 
 
Sato, K., Sato, M., Nakano, A., 2001. Rer1p, a retrieval receptor for endoplasmic 
reticulum membrane proteins, is dynamically localized to the Golgi apparatus 
by coatomer. Journal of Cell Biology 152, 935-944. 
 
Schindler, R., Itin, C., Zerial, M., Lottspeich, F., Hauri, H.P., 1993. ERGIC-53, a 
membrane protein of the ER-Golgi intermediate compartment, carries an ER 
retention motif. European Journal of Cell Biology 61, 1-9. 
 
Schweizer, A., Fransen, J.A.M., Bachi, T., Ginsel, L., Hauri, H.P., 1988. Identification, 
by a Monoclonal Antibody, of a 53-kD Protein Associated with a Tubulo-
Vesicular Compartment at the cis-side of the Golgi Apparatus. Journal of Cell 
Biology 107, 1643-1653. 
 
Serafini, T., Orci, L., Amherdt, M., Brunner, M., Kahn, R.A., Rothman, J.E., 1991. 
ADP-Ribosylation Factor Is a Subunit of the Coat of Golgi-derived COP-
Coated Vesicles: A Novel Role for a GTP-Binding Protein. Cell 67, 239-253. 
 
Shamu, C.E., Walter, P., 1996. Oligomerization and phosphorylation of the Ire1p 
kinase during intracellular signaling from the endoplasmic reticulum to the 
nucleus. EMBO Journal 15, 3028-3039. 
 
Shen, J.S., Chen, X., Hendershot, L., Prywes, R., 2002a. ER stress regulation of ATF6 
localization by dissociation of BiP/GRP78 binding and unmasking of golgi 
localization signals. Developmental Cell 3, 99-111. 
 
Shen, Y., Hendershot, L.M., 2005. ERdj3, a stress-inducible endoplasmic reticulum 
DnaJ homologue, serves as a cofactor for BiP's interactions with unfolded 
substrates. Molecular Biology of the Cell 16, 40-50. 
 
  63
Shen, Y., Meunier, L., Hendershot, L.M., 2002b. Identification and characterization of 
a novel endoplasmic reticulum (ER) DnaJ homologue, which stimulates 
ATPase activity of BiP in vitro and is induced by ER stress. Journal of 
Biological Chemistry 277, 15947-15956. 
 
Shikano, S., Li, M., 2003. Membrane receptor trafficking: Evidence of proximal and 
distal zones conferred by two independent endoplasmic reticulum localization 
signals. Proceedings of the National Academy of Sciences of the United States 
of America 100, 5783-5788. 
 
Shiu, R.P.C., Pouyssegur, J., Pastan, I., 1977. Glucose depletion accounts for induction 
of two transformation-sensitive membrane proteins in Rous sarcoma virus-
transformed chick embryo fibroblasts. Proceedings of the National Academy of 
Sciences of the United States of America 74, 3840-3844. 
 
Sitia, R., Meldolesi, J., 1992. Endoplasmic-reticulum - a dynamic patchwork of 
specialized subregions. Molecular Biology of the Cell 3, 1067-1072. 
 
Slepenkov, S.V., Witt, S.N., 2002. The unfolding story of the Escherichia coli Hsp70 
DnaK: is DnaK a holdase or an unfoldase? Molecular Microbiology 45, 1197-
1206. 
 
Stagg, S.M., Gurkan, C., Fowler, D.M., LaPointe, P., Foss, T.R., Potter, C.S., 
Carragher, B., Balch, W.E., 2006. Structure of the Sec13/31 COPII coat cage. 
Nature 439, 234-238. 
 
Tang, N.M., Ho, C.Y., Katze, M.G., 1996. The 58-kDa cellular inhibitor of the double 
stranded RNA-dependent protein kinase requires the tetratricopeptide repeat 6 
and DnaJ motifs to stimulate protein synthesis in vivo. Journal of Biological 
Chemistry 271, 28660-28666. 
 
Tao, J.H., Petrova, K., Ron, D., Sha, B.D., 2010. Crystal Structure of P58(IPK) TPR 
Fragment Reveals the Mechanism for its Molecular Chaperone Activity in 
UPR. Journal of Molecular Biology 397, 1307-1315. 
 
Thor, F., Gautschi, M., Geiger, R., Helenius, A., 2009. Bulk Flow Revisited: Transport 
of a Soluble Protein in the Secretory Pathway. Traffic 10, 1819-1830. 
Tisdale, E.J., Plutner, H., Matteson, J., Balch, W.E., 1997. p53/58 binds COPI and is 
required for selective transport through the early secretory pathway. Journal of 
Cell Biology 137, 581-593. 
 
Travers, K.J., Patil, C.K., Wodicka, L., Lockhart, D.J., Weissman, J.S., Walter, P., 
2000. Functional and genomic analyses reveal an essential coordination 
between the unfolded protein response and ER-associated degradation. Cell 
101, 249-258. 
 
Tsai, J., Douglas, M.G., 1996. A conserved HPD sequence of the J-domain is necessary 
for YDJ1 stimulation of Hsp70 ATPase activity at a site distinct from substrate 
binding. Journal of Biological Chemistry 271, 9347-9354. 
 
 
  64
Vainio, P., Mpindi, J.P., Kohonen, P., Fey, V., Mirtti, T., Alanen, K.A., Perala, M., 
Kallioniemi, O., Iljin, K., 2012. High-Throughput Transcriptomic and RNAi 
Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug 
Targets in Prostate Cancer. PLoS ONE 7, e39801. 
 
van Huizen, R., Martindale, J.L., Gorospe, M., Holbrook, N.J., 2003. P58(IPK), a novel 
endoplasmic reticulum stress-inducible protein and potential negative regulator 
of eIF2 alpha signaling. Journal of Biological Chemistry 278, 15558-15564. 
 
Velloso, L.M., Svensson, K., Pettersson, R.F., Lindqvist, Y., 2003. The crystal structure 
of the carbohydrate-recognition domain of the glycoprotein sorting receptor 
p58/ERGIC-53 reveals an unpredicted metal-binding site and conformational 
changes associated with calcium ion binding. Journal of Molecular Biology 
334, 845-851. 
 
Velloso, L.M., Svensson, K., Schneider, G., Pettersson, R.F., Lindqvist, Y., 2002. 
Crystal structure of the carbohydrate recognition domain of p58/ERGIC-53, a 
protein involved in glycoprotein export from the endoplasmic reticulum. 
Journal of Biological Chemistry 277, 15979-15984. 
 
Vembar, S.S., Jonikas, M.C., Hendershot, L.M., Weissman, J.S., Brodsky, J.L., 2010. J 
Domain Co-chaperone Specificity Defines the Role of BiP during Protein 
Translocation. Journal of Biological Chemistry 285, 22484-22494. 
 
Veratti, E., 1961. Investigations on fine structure of striated muscle fiber. Journal of 
Biophysical and Biochemical Cytology 10, 1-59. 
 
Vitu, E., Gross, E., Greenblaft, H.M., Sevier, C.S., Kaiser, C.A., Fass, D., 2008. Yeast 
Mpd1p Reveals the Structural Diversity of the Protein Disulfide Isomerase 
Family. Journal of Molecular Biology 384, 631-640. 
 
Vogel, M., Bukau, B., Mayer, M.P., 2006. Allosteric regulation of Hsp70 chaperones 
by a proline switch. Molecular Cell 21, 359-367. 
 
Vollenweider, F., Kappeler, F., Itin, C., Hauri, H.P., 1998. Mistargeting of the lectin 
ERGIC-53 to the endoplasmic reticulum of HeLa cells impairs the secretion of 
a lysosomal enzyme. Journal of Cell Biology 142, 377-389. 
 
Vos, M.J., Hageman, J., Carra, S., Kampinga, H.H., 2008. Structural and functional 
diversities between members of the human HSPB, HSPH, HSPA, and DNAJ 
chaperone families. Biochemistry 47, 7001-7011. 
 
Votsmeier, C., Gallwitz, D., 2001. An acidic sequence of a putative yeast Golgi 
membrane protein binds COPII and facilitates ER export. EMBO Journal 20, 
6742-6750. 
 
Walter, P., Ron, D., 2011. The Unfolded Protein Response: From Stress Pathway to 
Homeostatic Regulation. Science 334, 1081-1086. 
 
 
 
  65
Wang, X.D., Matteson, J., An, Y., Moyer, B., Yoo, J.S., Bannykh, S., Wilson, I.A., 
Riordan, J.R., Balch, W.E., 2004. COPII-dependent export of cystic fibrosis 
transmembrane conductance regulator from the ER uses a di-acidic exit code. 
Journal of Cell Biology 167, 65-74. 
 
Wang, X.Z., Kuroda, M., Sok, J., Batchvarova, N., Kimmel, R., Chung, P., Zinszner, 
H., Ron, D., 1998. Identification of novel stress-induced genes downstream of 
chop. EMBO Journal 17, 3619-3630. 
 
Waters, M.G., Serafini, T., Rothman, J.E., 1991. Coatomer - a cytosolic protein 
complex containing subunits of non-clathrin-coated golgi transport vesicles. 
Nature 349, 248-251. 
 
Welsh, L.M., Tong, A.H.Y., Boone, C., Jensen, O.N., Otte, S., 2006. Genetic and 
molecular interactions of the Erv41p-Erv46p complex involved in transport 
between the endoplasmic reticulum and Golgi complex. Journal of Cell Science 
119, 4730-4740. 
 
Wendeler, M.W., Paccaud, J.P., Hauri, H.P., 2007. Role of Sec24 isoforms in selective 
export of membrane proteins from the endoplasmic reticulum. EMBO Reports 
8, 258-264. 
 
Wieland, F.T., Gleason, M.L., Serafini, T.A., Rothman, J.E., 1987. The rate of bulk 
flow from the endoplasmic-reticulum to the cell-surface. Cell 50, 289-300. 
 
Wigren, E., Bourhis, J.M., Kursula, I., Guy, J.E., Lindqvist, Y., 2010. Crystal structure 
of the LMAN1-CRD/MCFD2 transport receptor complex provides insight into 
combined deficiency of factor V and factor VIII. Febs Letters 584, 878-882. 
 
Wilson, C., Venditti, R., Rega, L.R., Colanzi, A., D'Angelo, G., De Matteis, M.A., 
2011. The Golgi apparatus: an organelle with multiple complex functions. 
Biochemical Journal 433, 1-9. 
 
Wilson, D.W., Lewis, M.J., Pelham, H.R.B., 1993. pH-dependent binding of KDEL to 
its receptor invitro. Journal of Biological Chemistry 268, 7465-7468. 
 
Wu, M.S., Tu, T., Huang, Y.C., Cao, Y., 2013. Suppression subtractive hybridization 
identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a 
novel lung cancer-related gene. Bmc Cancer 13, 44. 
 
Yamada, T., Fujimori, Y., Suzuki, A., Miyawaki, Y., Takagi, A., Murate, T., Sano, M., 
Matsushita, T., Saito, H., Kojima, T., 2009. A novel missense mutation causing 
abnormal LMAN1 in a Japanese patient with combined deficiency of factor V 
and factor VIII. American Journal of Hematology 84, 738-742. 
 
Yan, W., Frank, C.L., Korth, M.J., Sopher, B.L., Novoa, I., Ron, D., Katze, M.G., 
2002. Control of PERK eIF2 alpha kinase activity by the endoplasmic reticulum 
stress-induced molecular chaperone P58(IPK). Proceedings of the National 
Academy of Sciences of the United States of America 99, 15920-15925. 
 
  66
Yap, K.L., Ames, J.B., Swindells, M.B., Ikura, M., 1999. Diversity of conformational 
states and changes within the EF-hand protein superfamily. Proteins: Structure 
Function and Genetics 37, 499-507. 
 
Yoshida, H., Haze, K., Yanagi, H., Yura, T., Mori, K., 1998. Identification of the cis-
acting endoplasmic reticulum stress response element responsible for 
transcriptional induction of mammalian glucose-regulated proteins - 
Involvement of basic leucine zipper transcription factors. Journal of Biological 
Chemistry 273, 33741-33749. 
 
Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., Mori, K., 2001. XBP1 mRNA is 
induced by ATF6 and spliced by IRE1 in response to ER stress to produce a 
highly active transcription factor. Cell 107, 881-891. 
 
Yoshihisa, T., Barlowe, C., Schekman, R., 1993. Requirement for a GTPase-activating 
protein in vesicle budding from the endoplasmic-reticulum. Science 259, 1466-
1468. 
 
Zahedi, R.P., Volzing, C., Schmitt, A., Frien, M., Jung, M., Dudek, J., Wortelkamp, S., 
Sickmann, A., Zimmermann, R., 2009. Analysis of the membrane proteome of 
canine pancreatic rough microsomes identifies a novel Hsp40, termed ERj7. 
Proteomics 9, 3463-3473. 
 
Zerangue, N., Schwappach, B., Jan, Y.N., Jan, L.Y., 1999. A new ER trafficking signal 
regulates the subunit stoichiometry of plasma membrane K-ATP channels. 
Neuron 22, 537-548. 
 
Zeytuni, N., Zarivach, R., 2012. Structural and Functional Discussion of the Tetra-
Trico-Peptide Repeat, a Protein Interaction Module. Structure 20, 397-405. 
 
Zhang, B., Kaufman, R.J., Ginsburg, D., 2005. LMAN1 and MCFD2 form a cargo 
receptor complex and interact with coagulation factor VIII in the early secretory 
pathway. Journal of Biological Chemistry 280, 25881-25886. 
 
Zhang, B., Cunningham, M.A., Nichols, W.C., Bernat, J.A., Seligsohn, U., Pipe, S.W., 
McVey, J.H., Schulte-Overberg, U., de Bosch, N.B., Ruiz-Saez, A., White, 
G.C., Tuddenham, E.G.D., Kaufman, R.J., Ginsburg, D., 2003. Bleeding due to 
disruption of a cargo-specific ER-to-Golgi transport complex. Nature Genetics 
34, 220-225. 
 
Zhang, B., Spreafico, M., Zheng, C., Yang, A., Platzer, P., Callaghan, M.U., Avci, Z., 
Ozbek, N., Mahlangu, J., Haw, T., Kaufman, R.J., Marchant, K., Tuddenham, 
E.G.D., Seligsohn, U., Peyvandi, F., Ginsburg, D., 2008. Genotype-phenotype 
correlation in combined deficiency of factor V and factor VIII. Blood 111, 
5592-5600. 
 
Zhang, B., McGee, B., Yamaoka, J.S., Guglielmone, H., Downes, K.A., Minoldo, S., 
Jarchum, G., Peyvandi, F., de Bosch, N.B., Ruiz-Saez, A., Chatelain, B., 
Olpinski, M., Bockenstedt, P., Sperl, W., Kaufman, R.J., Nichols, W.C., 
Tuddenham, E.G.D., Ginsburg, D., 2006. Combined deficiency of factor V and 
factor VIII is due to mutations in either LMAN1 or MCFD2. Blood 107, 1903-
1907. 
  67
Zhang, K.Z., Kaufman, R.J., 2006. The unfolded protein response - A stress signaling 
pathway critical for health and disease. Neurology 66, S102-S109. 
 
Zhang, L.Y., Liu, M., Li, X., Tang, H., 2013. miR-490-3p Modulates Cell Growth and 
Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by 
Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 
(ERGIC3). Journal of Biological Chemistry 288, 4035-4047. 
 
Zhang, X.P., Dong, C.M., Wu, Q.J., Balch, W.E., Wu, G.Y., 2011. Di-acidic Motifs in 
the Membrane-distal C Termini Modulate the Transport of Angiotensin II 
Receptors from the Endoplasmic Reticulum to the Cell Surface. Journal of 
Biological Chemistry 286, 20525-20535. 
 
Zheng, C.L., Zhang, B., 2013. Combined Deficiency of Coagulation Factors V and 
VIII: An Update. Seminars in Thrombosis and Hemostasis 39, 613-620. 
 
Zheng, C.L., Liu, H.H., Yuan, S.G., Zhou, J.H., Zhang, B., 2010. Molecular basis of 
LMAN1 in coordinating LMAN1-MCFD2 cargo receptor formation and ER-to-
Golgi transport of FV/FVIII. Blood 116, 5698-5706. 
 
Zinszner, H., Kuroda, M., Wang, X.Z., Batchvarova, N., Lightfoot, R.T., Remotti, H., 
Stevens, J.L., Ron, D., 1998. CHOP is implicated in programmed cell death in 
response to impaired function of the endoplasmic reticulum. Genes & 
Development 12, 982-995. 
 
 
 
 
